RESOURCES


home.aspx
   
RNA Targeting Poised To Share The Spotlight With Gene Therapy RNA TARGETING POISED TO SHARE THE SPOTLIGHT WITH GENE THERAPY

blog article

Jan 16, 2020

As the biopharma industry concludes its annual pilgrimage to San Francisco for the JP Morgan investor conference, much of the talk around town inevitably was about gene therapies. Rightfully so, considering the therapeutic promise of such one-time cures, and the spate of M&A activity for gene th...

Read More

Drug Store Check-In DRUG STORE CHECK-IN

blog article

Jan 16, 2020

The Pharmacy sector has become one of the most interesting sectors in retail because of the expanding ambitions of some of its leading players, and the appeal from the potential entry of retail’s largest giants. We broke down some of the sector’s classic leaders to see who’s positi...

Read More

Top 10 PBM Industry Macrotrends in 2019 & What to Expect in 2020 TOP 10 PBM INDUSTRY MACROTRENDS IN 2019 & WHAT TO EXPECT IN 2020

blog article

Jan 14, 2020

The PBM industry saw some significant changes in 2019, as some of the largest forces in the market vertically integrated and began implementing disruptive programs that redefined the way pharmacy claims are processed in the U.S. The disruptive strategies spanned from drug acquisition (the way PBMs n...

Read More

USP 800 Compliance for Compounding Pharmacies & Labratories USP 800 COMPLIANCE FOR COMPOUNDING PHARMACIES & LABRATORIES

blog article

Jan 14, 2020

If you’re reading this now, chances are you’re doing so with a bit of anxiety … and your anxiety is justified by the December 1, 2019 deadline for United States Pharmacopeia (USP) Chapter <800>.  You’re not alone. Other compounding facilities are in a rush to make...

Read More

Pharmacy Industry Updates: January PHARMACY INDUSTRY UPDATES: JANUARY

blog article

Jan 10, 2020

Every month, our Industry Relations Director, LeAnn Lewis provides an in-depth industry update to customers. Below, you will find an agenda for the industry update for January. If you have any questions regarding any of the points, contact us here.

Read More

Medical Device Reps Do More Than You Think! MEDICAL DEVICE REPS DO MORE THAN YOU THINK!

blog article

Jan 09, 2020

The medical device industry has experienced a boom in recent years, this has gone hand in hand with the development of state-of-the-art devices that provide greater benefits to patients. Medical devices are instruments and implements used in the diagnosis or treatment of various pathologies; Medical...

Read More

Cold and Flu Prevention: Fact vs. Fiction COLD AND FLU PREVENTION: FACT VS. FICTION

blog article

Jan 08, 2020

Cold and flu season is here. The common cold, often caused by rhinoviruses, is the most common human illness and comes with generally mild symptoms. The flu, caused by the influenza virus, can have more complicated symptoms. Both are contagious. So, what can you do to not get sick? That’s a qu...

Read More

Everything to Know About Generic Drugs Coming To Market in 2020 EVERYTHING TO KNOW ABOUT GENERIC DRUGS COMING TO MARKET IN 2020

blog article

Jan 08, 2020

Every year, the patents on prescription drugs expire, allowing other manufacturers to produce generic versions of brand-name drugs.  In past years, drugs like Claritin became loratadine, Prilosec became omeprazole, and Pravachol became pravastatin. Each time a brand-name drug becomes generic, w...

Read More

4 Performance Trends to Guide Your Independent Pharmacy in 2020 4 PERFORMANCE TRENDS TO GUIDE YOUR INDEPENDENT PHARMACY IN 2020

blog article

Jan 06, 2020

I’m optimistic about what 2020 and the new decade holds for your pharmacy and all independents across the country. That’s because there are opportunities for you to take advantage of four new performance trends. Each gives you the chance to show payers the great care that you provide to ...

Read More

Growing concerns about Fentanyl GROWING CONCERNS ABOUT FENTANYL

blog article

Jan 06, 2020

Last Friday (3 January 2020) the Advisory Council on the Misuse of Drugs (ACMD) published a new report on the Misuse of Fentanyl (and Fentanyl analogues). As many readers will know, Fentanyl is a licensed medicine used for anaesthesia and pain management. Like morphine, heroin, codeine and other &ls...

Read More

How AI is transforming the way we collect market insights HOW AI IS TRANSFORMING THE WAY WE COLLECT MARKET INSIGHTS

blog article

Jan 02, 2020

It is a very real application of Artificial Intelligence (AI), a technology that has fast become an integral part of our daily lives. With all of the hype surrounding the more attention-grabbing applications of AI such as self-driving cars and super human-like robots – which most commentators ...

Read More

Third-Party Medicine Manufacturer: Everything that you Need to Know THIRD-PARTY MEDICINE MANUFACTURER: EVERYTHING THAT YOU NEED TO KNOW

blog article

Jan 02, 2020

Before heading toward a detailed view about third party manufacturers of medicine, we first need to know that what really third party medicine manufacturers are? And how they work? So we can simply understand or define a third party medicine manufacturer as that outsource when a company or manufactu...

Read More

Get Aware Of Lucrative PCD Products To Start Company GET AWARE OF LUCRATIVE PCD PRODUCTS TO START COMPANY

blog article

Dec 27, 2019

Pharma franchise is an agreement or authorized permission or sanction established by pharma company to suppliers, group or separate company Franchise Company offers privileges to franchisee to expand its business with the benefit of Franchise Company. In the past few years, it has been seen a tremen...

Read More

Can We Talk? Rethinking FDA Communications With Drug Developers CAN WE TALK? RETHINKING FDA COMMUNICATIONS WITH DRUG DEVELOPERS

blog article

Dec 25, 2019

When it comes to 21st-century drug development, is the Food and Drug Administration (FDA) an accelerator or anchor for medical innovation? If the former, how can it do even better? If the latter, how big of a sea change is required? To address that question head on, the FDA held a November 7 hearing...

Read More

Kratom – New Data on a Controversial Drug KRATOM – NEW DATA ON A CONTROVERSIAL DRUG

blog article

Dec 20, 2019

Kratom is a mind-altering substance that has bounced on and off the radar for the last decade. Occasionally, we’ll hear news blurbs about this drug, a story here and there of someone who died from using it. But the substance is still legal, and there is even a strong advocacy movement to keep ...

Read More

Polymer Vial Containment Systems for Gene Therapy Drug Products POLYMER VIAL CONTAINMENT SYSTEMS FOR GENE THERAPY DRUG PRODUCTS

blog article

Dec 20, 2019

Recently, there has been discussion in the industry regarding the utility of polymer-based vial containment systems for the storage and transport of gene therapy drug products, which can be performed as low as -80oC. Since it is known that all polymers are gas permeable, discussion has centered on w...

Read More

Education and Teamwork EDUCATION AND TEAMWORK

blog article

Dec 18, 2019

What’s the best way to improve performance and optimize the care of patients using the EQuIPP™ platform? The answer is quite simple. Education and teamwork! After a recent user group meeting, it’s clear that pharmacists are striving to improve adherence and want to know better ways...

Read More

Increasing HCP Engagement Through Speaker Program Technology INCREASING HCP ENGAGEMENT THROUGH SPEAKER PROGRAM TECHNOLOGY

blog article

Dec 18, 2019

Building meaningful relationships with HCPs is key to pharmaceutical sales success, and so it’s crucial for medcomm agencies. In this blog, we’ll show you how you can start using speaker program technology to increase engagement with HCPs and pharma for better program ROI. Life Science c...

Read More

Protect Your Website from Pharma Hack Traffic PROTECT YOUR WEBSITE FROM PHARMA HACK TRAFFIC

blog article

Dec 16, 2019

We often get requests like this one: "We're experiencing a massive spam URL injection issue on our site. Almost every page on our site has unauthorized pharmaceutical ads with links to seller sites. Please help!" What has hit them is the "pharma hack." Website owners too ofte...

Read More

How Purdue Pharma Is Cashing In On Both Sides Of The Opioid Epidemic HOW PURDUE PHARMA IS CASHING IN ON BOTH SIDES OF THE OPIOID EPIDEMIC

blog article

Dec 16, 2019

One of the company's affiliates is pushing hard to market naloxone, an anti-overdose medication. “You’re in the business of selling medicine that causes addiction and overdoses, and now you’re in the business of selling medicine that treats addiction and overdoses?” asked...

Read More

5 Advantages Of Having An Online Pharmacy 5 ADVANTAGES OF HAVING AN ONLINE PHARMACY

blog article

Dec 12, 2019

As online businesses expand on a day-to-day basis, the pharmaceutical industry isn’t being left behind. The statistics speak for themselves. In 2014, the global online pharmacy market was estimated to be worth 29 billion U.S. dollars on average. And by 2023, it’s predicted that the marke...

Read More

Seniors Need More Medication Reviews SENIORS NEED MORE MEDICATION REVIEWS

blog article

Dec 12, 2019

It has been a busy week for studies focusing on complex care in older adults.  Two new studies provided some insight on the amount of medications older adults use, and the problems they are having with these medications.  Here are links to the articles: Polypharmacy and Pharmacological Tre...

Read More

First-Ever Decline in Prescription Drug Prices in US in 45 Years FIRST-EVER DECLINE IN PRESCRIPTION DRUG PRICES IN US IN 45 YEARS

blog article

Dec 10, 2019

Reduction in the price of prescription drugs is a rare event. Several factors could be responsible for a decline in prices that affects the overall pharmaceutical industry. The US witnessed 1% reduction in the prices of prescription drugs in 2018, as revealed by the government.  Despite the mod...

Read More

How does prevalence affect pricing of rare disease drugs? HOW DOES PREVALENCE AFFECT PRICING OF RARE DISEASE DRUGS?

blog article

Dec 10, 2019

New research from CRA looks at the relationship between rarity of a disease and the price countries are willing to pay for drugs to treat them. High clinical development costs and small target patient populations have often been presented as justifications for high prices of drugs to treat rare dise...

Read More

How AI is Shaping the Future of the Pharmaceutical Industry HOW AI IS SHAPING THE FUTURE OF THE PHARMACEUTICAL INDUSTRY

blog article

Dec 02, 2019

Artificial Intelligence and Machine Learning are powering incredible changes across a huge range of industries. But in data and research-dependent industries such as pharmaceuticals, they’re having an unparalleled impact. From improving candidate selection processes for clinical trials, to acc...

Read More

Is the opioid crisis mainly a story of ‘late capitalism’ or something more complicated? IS THE OPIOID CRISIS MAINLY A STORY OF ‘LATE CAPITALISM’ OR SOMETHING MORE COMPLICATED?

blog article

Dec 02, 2019

For capitalism’s critics, the opioid crisis is a powerful witness for the prosecution. They charge that inequality, stagnant wages, immobility, job loss — the four horsemen of the neoliberalism endgame — have generated a massive surge in “deaths of despair,” especially ...

Read More

Could AI create a brave new world of pharma R&D? COULD AI CREATE A BRAVE NEW WORLD OF PHARMA R&D?

blog article

Nov 29, 2019

Barely a week goes by without one big pharma or biotech announcing that it is using AI to develop new medicines. Richard Staines looks at the progress already made thanks to this potentially revolutionary technology, and how it could change the fortunes of a beleaguered pharma industry. Artificial I...

Read More

A safer ride: the latest innovation in targeted cancer treatment A SAFER RIDE: THE LATEST INNOVATION IN TARGETED CANCER TREATMENT

blog article

Nov 28, 2019

One downside of the antibody-drug conjugates used in oncology today is that the drug-carrying antibodies can shed much of their toxic cargo on the way to the tumour site. Now, German researchers have published their method for attaching drugs to antibodies with greater stability, potentially making ...

Read More

Modern pharma grows more colourful MODERN PHARMA GROWS MORE COLOURFUL

blog article

Nov 28, 2019

The modern pharmacy retail segment is welcoming an exciting new entrant in Japanese drug and cosmetics retailer Matsumotokiyoshi Co., Ltd, urging existing players to dust down their racing goggles. Matsumotokiyoshi has agreed to form a joint venture with Lotus Food Group JSC to operate a drugstore c...

Read More

Silos in Pharma – The Data Issue SILOS IN PHARMA – THE DATA ISSUE

blog article

Nov 28, 2019

A key component of product innovation in the pharmaceutical industry is the analysis of data. Yet, the Pharma industry can be diagnosed as suffering with one particular problem: the prevalence of data silos. Often stored across disparate tools and locations, the isolation of data severely impacts th...

Read More

How does CBD affect your memory? HOW DOES CBD AFFECT YOUR MEMORY?

blog article

Nov 27, 2019

One of the great benefits of smoking marijuana is that there’s rarely any hangovers on the following day. Sadly, the plant still has the capability of rattling your memories. Cannabis, or THC more precisely, tends to affect people’s cognitive function and short term memory skills, which ...

Read More

Where the Nurse Prescribes Heroin WHERE THE NURSE PRESCRIBES HEROIN

blog article

Nov 27, 2019

A new program in Glasgow will give drug users pharmaceutical-grade heroin twice daily in a bid to reduce drug-related deaths. Homeless drug users in Scotland will be allowed to inject pharmaceutical-grade heroin twice a day under the supervision of medical officials as part of a new program intended...

Read More

Pharmaceutical Industry Is Adopting AI On Numerous Fronts PHARMACEUTICAL INDUSTRY IS ADOPTING AI ON NUMEROUS FRONTS

blog article

Nov 25, 2019

The pharmaceutical industry is adopting artificial intelligence (AI) on numerous fronts, from discovery and clinical development to risk assessment and safety monitoring, regulatory, and manufacturing. Pharmaceutical and biotechnology companies, as well as service providers now, rely on AI technolog...

Read More

Pharma Cold chain tracking : a prototype PHARMA COLD CHAIN TRACKING : A PROTOTYPE

blog article

Nov 22, 2019

Innovation with the Internet of Things(IoT) has been an on-going effort. Although IoT appeared in the Gartner hype cycle for 2017, it has been around for a very long time and businesses have experimented with this technology since the time we can remember. It’s only in the recent past that cos...

Read More

4 Common Misconceptions About Cold Chain Logistics 4 COMMON MISCONCEPTIONS ABOUT COLD CHAIN LOGISTICS

blog article

Nov 22, 2019

When it comes to shipping pharmaceuticals, we use cold chain materials to control the temperature of your drugs or medicines from the manufacturer through a delivery to the end user. It’s critical to keep these within the proper temperature range because they can be rendered useless or even ha...

Read More

Are medtech companies ready for the robotics digital data revolution? ARE MEDTECH COMPANIES READY FOR THE ROBOTICS DIGITAL DATA REVOLUTION?

blog article

Nov 22, 2019

The ultimate value that robotics data will provide is in improving outcomes through better recording of process, approach, measurements and outcomes data. Collected through an individual robot in one OR, that data is likely interesting, but not significantly valuable. It’s also not linked to t...

Read More

Digital Transformation: A Guide for Pharma Marketers DIGITAL TRANSFORMATION: A GUIDE FOR PHARMA MARKETERS

blog article

Nov 21, 2019

Artificial intelligence (AI) and machine learning (ML) are not yet perfect sciences, but they are transforming life sciences companies in practical and meaningful ways. This includes improving targeting and relationships with healthcare providers (HCPs) and patients. However, organizations need to b...

Read More

Coughs and sneezes spread diseases: charting the development of flu vaccines COUGHS AND SNEEZES SPREAD DISEASES: CHARTING THE DEVELOPMENT OF FLU VACCINES

blog article

Nov 21, 2019

Vaccines have been established as the most effective method of preventing flu since the early 20th century, however, much has changed in the past century to improve effectiveness, administration and adherence in the face of flu viruses’ constant mutation. Allie Nawrat charts the development of...

Read More

What to know about cannabis advertising in 2020 WHAT TO KNOW ABOUT CANNABIS ADVERTISING IN 2020

blog article

Nov 21, 2019

If you are a business owner you might know advertising can be challenging at times, especially if you are an owner of a Cannabis Dispensary or CBD Shop. You are not sure where to start. You might ask yourself do I need someone to help me with this? What are the laws, rules and regulations for advert...

Read More

5 Things a Landlord Should Know About Recreational Cannabis in Illinois 5 THINGS A LANDLORD SHOULD KNOW ABOUT RECREATIONAL CANNABIS IN ILLINOIS

blog article

Nov 21, 2019

Registered qualifying patients under the Compassionate Use of Medical Cannabis Pilot Program Act, are granted certain exceptions for possession volume and cultivation of cannabis. Further, the CRTA does not permit any person to smoke cannabis in any place where smoking is already prohibited under th...

Read More

Searching Chemical Spaces to Boost Drug Development SEARCHING CHEMICAL SPACES TO BOOST DRUG DEVELOPMENT

blog article

Nov 20, 2019

In drug discoverers’ jargon, large collections of molecules are known as chemical spaces. Whereas chemical spaces only contained a few million molecules some years ago, they now hold tens of billions of molecules. In addition, previously “virtual” molecules can now be purchased and...

Read More

Pharma Cyber Security: How to Tackle Malware Threats PHARMA CYBER SECURITY: HOW TO TACKLE MALWARE THREATS

blog article

Nov 20, 2019

The global pharmaceutical market is expected to grow to almost 1.2 billion by 2021,1 thanks in part to rapid advancements in digital automation and innovation. Unfortunately, these growth-generating strategies also open pharma manufacturers up to new risks. For example, acquisitions and outsourcing ...

Read More

5 Essentials for a Successful Pharmaceutical Advisory Board Meeting 5 ESSENTIALS FOR A SUCCESSFUL PHARMACEUTICAL ADVISORY BOARD MEETING

blog article

Nov 19, 2019

It happens all the time across the pharmaceutical industry: you’ve been tasked with understanding customer perceptions better, but your budget and timelines are limited.  In these situations, an Advisory Board can be an incredibly valuable tool.  Advisory Board meetings help manufact...

Read More

Minimizing Risk Within the Pharmaceutical Supply Chain MINIMIZING RISK WITHIN THE PHARMACEUTICAL SUPPLY CHAIN

blog article

Nov 19, 2019

The U.S. pharmaceutical supply chain is responsible for providing patients safe, secure and timely access to more than 4 billion prescription medicines every year. Sustaining this complex supply chain requires the collaboration between a diverse group of partners, including manufacturers, distributo...

Read More

The Medicine Plant That Could Have Changed the World. THE MEDICINE PLANT THAT COULD HAVE CHANGED THE WORLD.

blog article

Nov 18, 2019

Growing up in Tanzania, I knew that fruit trees were useful. Climbing a mango tree to pick a fruit was a common thing to do when I was hungry, even though at times there were unintended consequences. My failure to resist consuming unripened fruit, for example, caused my stomach to hurt. With such in...

Read More

Welcome to the future of pharma WELCOME TO THE FUTURE OF PHARMA

blog article

Nov 18, 2019

Innovation in pharma is playing a key role in transforming science, healthcare and even the wider society. From the chance discovery of penicillin to the Human Genome Project – one of the world’s largest collaborative scientific endeavours – we have seen the eradication of devastat...

Read More

Four predictions on the future of personalised medicine FOUR PREDICTIONS ON THE FUTURE OF PERSONALISED MEDICINE

blog article

Nov 18, 2019

For as long as there have been people, there have been illness and disease to hobble them. From cancer to the common cold, these nemeses of the human condition aren’t just going to disappear overnight. But medical researchers are still making major headway in how we diagnose and treat differen...

Read More

How big pharma and startups can learn from each other HOW BIG PHARMA AND STARTUPS CAN LEARN FROM EACH OTHER

blog article

Nov 15, 2019

The way to accelerate benefit to patients changes over time as technology improves and innovation becomes more cutting edge. I’ve always looked for the more cutting-edge projects because, quite frankly, they’re just more intellectually stimulating for me. I like being on the vanguard whe...

Read More

What lower prices would mean for drug companies? WHAT LOWER PRICES WOULD MEAN FOR DRUG COMPANIES?

blog article

Nov 15, 2019

Drug pricing regulations would not decimate the pharmaceutical industry, according to an analysis from health policy researchers at West Health and Johns Hopkins. This throws some cold water on Big Pharma's claims that new drug research and investments would evaporate if the federal government l...

Read More

Does Your Scientific Narrative Resonate in the Pharmaceutical Ecosystem? DOES YOUR SCIENTIFIC NARRATIVE RESONATE IN THE PHARMACEUTICAL ECOSYSTEM?

blog article

Nov 14, 2019

Pharmaceutical communication is a foundational component of stakeholder engagement and management. In Europe, pharmaceutical communication traditionally focuses solely on interaction with prescribers, while in the US pharma communication also includes direct-to-consumer advertising. Strategic engage...

Read More

Advertising in newsletters accounts for a quarter of all pharmaceutical marketing ADVERTISING IN NEWSLETTERS ACCOUNTS FOR A QUARTER OF ALL PHARMACEUTICAL MARKETING

blog article

Nov 14, 2019

Today - with a full year of newsletter coverage - I would like to present excerpts from a new evaluation. All of the following figures relate to the period from January to October 2019. In January of this year, we once again dramatically increased the number of subscribed newsletters - from 100 to 2...

Read More

Could Cannabinoids Be Used To Treat PTSD? COULD CANNABINOIDS BE USED TO TREAT PTSD?

blog article

Nov 12, 2019

The use of cannabinoids to treat PTSD is becoming a much more common treatment regime. Historically, cannabinoids were difficult to prescribe, as national legislation restricted scientists from studying their therapeutic efficacy. Without this research and with the lack of a product monograph, in th...

Read More

WHY ETHANOL WORKS SO WELL FOR CANNABIS EXTRACTION WHY ETHANOL WORKS SO WELL FOR CANNABIS EXTRACTION

blog article

Nov 12, 2019

Cannabis comes with a lot of known health benefits to users with little to no side effects, unlike pharmaceutical drugs. Advancement in technology now allows manufacturers to extract various products infused within cannabis such as extracts, concentrates, edibles, etc. The use of ethanol in extracti...

Read More

Improving medicines adherence with VR IMPROVING MEDICINES ADHERENCE WITH VR

blog article

Nov 12, 2019

With medicine adherence still a major problem for pharma and healthcare systems, a collaboration between Cognitant Group and Addenbrooke’s Hospital –supported by grants from UCB and Pfizer – is piloting a programme that aims to educate patients through the power of virtual reality ...

Read More

Artificial Intelligence and Machine Learning/Translation in Pharma Language Translation ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING/TRANSLATION IN PHARMA LANGUAGE TRANSLATION

blog article

Nov 11, 2019

AI, in practice, has a lot of potential and also a lot of limitations. AI is being used to model, extrapolate, and automate tasks throughout the lifecycle of a drug (as it should be). The potential benefits are substantial, both in terms of clinical efficacy and financial savings. The low-hanging fr...

Read More

POLY HELPS EMPOWER CONTACT CENTER WORKERS POLY HELPS EMPOWER CONTACT CENTER WORKERS

blog article

Nov 11, 2019

It’s a well-documented trend that the rise of digital channels such as webchat, apps, FAQs, etc., has led to a change in the way contact centers handle interactions. The routine, “easy” interactions are now handled by self-service channels. Deflecting these low-value interactions h...

Read More

Collaboration Is the X Factor in Making Precision Medicine a Success COLLABORATION IS THE X FACTOR IN MAKING PRECISION MEDICINE A SUCCESS

blog article

Nov 11, 2019

Last year, the FDA approved 59 new molecular entities for the US market, the highest number ever approved in a single year. A key driver of this record level of approvals is the explosive growth of precision medicine. Since 2015, at least a fifth of all new drug approvals each year have been precisi...

Read More

The Impact of Synthesis Innovation in Drug Discovery THE IMPACT OF SYNTHESIS INNOVATION IN DRUG DISCOVERY

blog article

Nov 11, 2019

The term "process chemistry" describes the action of "scaling up" reactions – taking small quantities of a chemical compound and synthesizing it on a much greater scale. A process chemist is tasked with developing synthetic routes that are safe, cost-effective and efficient...

Read More

Virtual pharma – now for real? VIRTUAL PHARMA – NOW FOR REAL?

blog article

Nov 08, 2019

Over the last decades, the advances in medical science, the growing competition and the demands of the payers have led to permanent changes and adaptations of the pharma business model. Even the biggest companies do not do everything in-house. Instead, the industry has developed partnering as one ke...

Read More

Intelligent drug discovery: Powered by AI INTELLIGENT DRUG DISCOVERY: POWERED BY AI

blog article

Nov 08, 2019

Drug discovery is the process of identifying new medicines for treating or curing human diseases. While drug discovery has led to many life-saving and life-enhancing clinical treatments, historically the process has also been long, expensive, and often unsuccessful, with many areas of unmet need sti...

Read More

A PHARMA FIRST: FDA-APPROVED APP FOR TREATMENT OF ADDICTION A PHARMA FIRST: FDA-APPROVED APP FOR TREATMENT OF ADDICTION

blog article

Nov 06, 2019

It’s 2019. If technology is integrated into our daily lives when it comes to work, entertainment, and even social interactions, it shouldn’t come as a surprise that tech is also playing a major role in improving health outcomes. A 2018 study showed that 90% of Americans use digital healt...

Read More

First New HIV Strain in 19 Years Identified FIRST NEW HIV STRAIN IN 19 YEARS IDENTIFIED

blog article

Nov 06, 2019

A research group at the medical devices and health care giant Abbott has discovered a new strain of human immunodeficiency virus, or HIV—the first to be identified in 19 years. Abbott continues to look for potential new HIV strains to ensure that diagnostic tests for blood screening and detect...

Read More

How Key Pharma And Device Executives Are Developing The Next Generation Of Quality Professionals And Leaders HOW KEY PHARMA AND DEVICE EXECUTIVES ARE DEVELOPING THE NEXT GENERATION OF QUALITY PROFESSIONALS AND LEADERS

blog article

Nov 06, 2019

A team comprising over a dozen chief quality officers (CQOs) representing the medical device, pharmaceutical, animal health, and consumer healthcare industries has pooled its collective passion and wisdom—with input from FDA and other drug and device regulatory agencies—to establish and ...

Read More

What is Allometric Scaling and How Does it Support Drug Development? WHAT IS ALLOMETRIC SCALING AND HOW DOES IT SUPPORT DRUG DEVELOPMENT?

blog article

Nov 06, 2019

There are many aspects of drug development that must be understood before a drug can be tested in humans. Nonclinical studies are conducted to understand the safety (i.e., toxicity and safety pharmacology) of drug candidates and to provide critical pharmacokinetic (PK) information, including insight...

Read More

Mistakes to Be Avoided When Preparing a Drug Launch MISTAKES TO BE AVOIDED WHEN PREPARING A DRUG LAUNCH

blog article

Nov 05, 2019

The launch of a new product can be a daunting task. The main reason this happens is that no matter how many times your company has managed to enter new products on the market, chances are that not one initiative entirely resembled another. For better or for worse, there is not a single recipe for su...

Read More

Cancer drug discovery: unravelling the mysteries of halichondrin CANCER DRUG DISCOVERY: UNRAVELLING THE MYSTERIES OF HALICHONDRIN

blog article

Nov 05, 2019

A joint Harvard-Eisai project has achieved a breakthrough by fully synthesising the highly potent anti-cancer molecule halichondrin, sourced from marine sponges, at scale. It has taken 30 years of research to reach this point, so what has made halichondrin synthesis so difficult, and what are the im...

Read More

THE POWER OF DATA SCIENCE IN PHARMACEUTICALS THE POWER OF DATA SCIENCE IN PHARMACEUTICALS

blog article

Nov 04, 2019

The world population grows by more than 80 million per year, according to a 2017 report by the United Nations. By 2050, there will be 10 billion people on this planet and people over the age of 60 years and above are expected to double. It’s clear that a growing and aging world population need...

Read More

Top 9 Technology Trends That Will Transform “Medicine And Healthcare” In 2020 TOP 9 TECHNOLOGY TRENDS THAT WILL TRANSFORM “MEDICINE AND HEALTHCARE” IN 2020

blog article

Nov 03, 2019

Healthcare is an industry that is as of now being changed utilizing the most recent technology, so it can address the difficulties it is looking in the 21st century. Technology can help healthcare associations satisfy developing need and proficiently work to convey better patient consideration. Here...

Read More

We Need More than New Antibiotics to Fight Resistance WE NEED MORE THAN NEW ANTIBIOTICS TO FIGHT RESISTANCE

blog article

Nov 01, 2019

Metabolic disrupters, phages, and other approaches are going to be needed to treat the broadest possible range of patients infected by bacterial pathogens resistant to multiple drugs. In the summer of 1924, Calvin Jr., President Coolidge’s youngest son, developed a blister in his third right t...

Read More

Next-gen pneumococcal vaccines: a race to the finish or a foregone conclusion? NEXT-GEN PNEUMOCOCCAL VACCINES: A RACE TO THE FINISH OR A FOREGONE CONCLUSION?

blog article

Nov 01, 2019

Pneumococcal disease, defined as infections caused by the bacterium streptococcus pneumoniae, has long been a source of morbidity and mortality, particularly in infants and the elderly. Importantly, rates of pneumococcal disease have been significantly curtailed, largely in developed regions, due to...

Read More

Enforcement Actions Against Sartan Manufacturers ENFORCEMENT ACTIONS AGAINST SARTAN MANUFACTURERS

blog article

Oct 31, 2019

Health authorities worldwide have overseen the recall of many ‘sartan’ products in the past few years.  These recalls began in the US as early as 2013 with a recall of product by Teva Pharmaceuticals.  Authorities in the US, EMA, Canada, and Australia, just to name a few, have ...

Read More

Precision Medicine: How Far We’ve Come PRECISION MEDICINE: HOW FAR WE’VE COME

blog article

Oct 30, 2019

A decade ago, precision medicine was little more than an idea and a phrase. The term was coined in 2011 by the National Research Council, a non-government agency that advises the government on scientific matters. That year, the NRC issued a report calling for a new “data network” to brin...

Read More

Is semantic technology the AI sweet spot for pharma? IS SEMANTIC TECHNOLOGY THE AI SWEET SPOT FOR PHARMA?

blog article

Oct 25, 2019

Artificial intelligence (AI) has been trumpeted by many in the pharmaceutical industry as the magic bullet to the issues they face in drug discovery and other research. However, expectations need to be tempered because although it’s easy to get excited by the potential of AI it’s importa...

Read More

Drug Helps Plants Resist Drought: Study DRUG HELPS PLANTS RESIST DROUGHT: STUDY

blog article

Oct 24, 2019

An engineered small molecule called opabactin that targets the receptor for the hormone abscisic acid (ABA), which plants release in stressful conditions, limited water loss in Arabidopsis, tomato, and wheat, and improved wheat’s tolerance of drought-like conditions in the lab, according to a ...

Read More

When the Target Isn’t Really the Target: One Way Cancer Drugs Fall Out of Clinical Trials WHEN THE TARGET ISN’T REALLY THE TARGET: ONE WAY CANCER DRUGS FALL OUT OF CLINICAL TRIALS

blog article

Oct 24, 2019

Ninety-seven percent of potential new cancer drugs never make it to market, dropping out of clinical trials when they don’t meet measures of safety or efficacy. “Why that is, we don’t really know. But I think that this extremely high failure rate suggests that there are some fundam...

Read More

Mulesoft: how can API tools speed up drug development? MULESOFT: HOW CAN API TOOLS SPEED UP DRUG DEVELOPMENT?

blog article

Oct 24, 2019

At its Connect conference in London in early October, MuleSoft brought together its customers and clients across all sectors to discuss how enterprise software, and particularly APIs, can drive efficiencies and contribute to digital transformation. Mulesoft’s David Chao and AstraZeneca’s...

Read More

Drug Delivery DRUG DELIVERY

blog article

Oct 23, 2019

A drug’s efficacy can be impacted significantly by the way in which it is delivered. By developing a variety of drug delivery systems (DDSs) it is now possible to better control the pharmacokinetics, pharmacodynamics, toxicity, immunogenicity and efficacy of drugs. By finding the best-suited d...

Read More

Channeling the Power of AI into Personalizing Medicine CHANNELING THE POWER OF AI INTO PERSONALIZING MEDICINE

blog article

Oct 23, 2019

Artificial intelligence has been much discussed of late, but will it really help us solve important problems like how to bring personalized medicine to as many patients as possible? Kate Hilyard, COO of Healx in Cambridge in the UK, believes it can. Getting a drug to clinical trials currently requir...

Read More

BUILDING MORE PRODUCTIVITY INTO OUR HEADSETS WITH AMAZON ALEXA AND TILE BUILDING MORE PRODUCTIVITY INTO OUR HEADSETS WITH AMAZON ALEXA AND TILE

blog article

Oct 23, 2019

If you’re like me, one of the first things you do when you leave the house in the morning is put on your headset. I may be joining a meeting, calling a friend, getting coffee – sometimes all three – before I even set foot in the office. When I get to work, I’m collaborating w...

Read More

POLY STUDIO IS NOW CERTIFIED FOR MICROSOFT TEAMS POLY STUDIO IS NOW CERTIFIED FOR MICROSOFT TEAMS

blog article

Oct 22, 2019

It seems like every photo shown of a business in action these days features a bunch of people in a huddle room, looking productive – just like our own Poly beauty shot below. But the technology that is IN the room really matters most to the people who are joining remotely – the people NO...

Read More

Do Patients Care About What Your Drug Does? DO PATIENTS CARE ABOUT WHAT YOUR DRUG DOES?

blog article

Oct 22, 2019

In most randomized pharmaceutical clinical trials, researchers are looking for a statistically significant performance difference between the two courses of therapy. But which is more important to the patient: Statistically significant improvement of a variable, or clinically significant improvement...

Read More

Testing Medicines After Brexit: Upholding High QC Standards for Pharmaceuticals TESTING MEDICINES AFTER BREXIT: UPHOLDING HIGH QC STANDARDS FOR PHARMACEUTICALS

blog article

Oct 22, 2019

Maintaining robust quality control standards is a key priority for any commercial industry – but for pharmaceutical manufacturers, it can literally be a matter of life and death. The medical sector is one of the most stringently regulated in the world, and drugmakers recognize the importance o...

Read More

Why is pharma so bad at sharing clinical trial data? WHY IS PHARMA SO BAD AT SHARING CLINICAL TRIAL DATA?

blog article

Oct 21, 2019

Since the 90s, the requirements for pharmaceutical companies to register and report results from clinical trials have increased. But analysis published in the BMJ indicates that large pharmaceutical companies could be doing much more when it comes to sharing data. Over the last few decades, pharma c...

Read More

4 ways to talk with vaccine skeptics 4 WAYS TO TALK WITH VACCINE SKEPTICS

blog article

Oct 21, 2019

Your neighbor is telling you about his new baby. He feels nervous about vaccinating, and says he's considering delaying Lucy's vaccines. Your mother's group is chatting about vaccines. One mother tells the group Jimmy isn't vaccinated, and she's using the Immune-Strengthening Die...

Read More

Helping the Pharmaceutical Industry Tackle the Evolving Challenge of Water Quality HELPING THE PHARMACEUTICAL INDUSTRY TACKLE THE EVOLVING CHALLENGE OF WATER QUALITY

blog article

Oct 18, 2019

Water plays a vital role in a broad range of processes within the pharmaceutical industry, from its use as a reagent and solvent in drug synthesis, to its utilization in formulation development and analytical testing, all the way through to product packaging and labeling. Each application has its ow...

Read More

MEDICAL MARIJUANA AND THE DRUG-FREE WORKPLACE ACT MEDICAL MARIJUANA AND THE DRUG-FREE WORKPLACE ACT

blog article

Oct 17, 2019

Presently 33 states and the District of Columbia have enacted medical marijuana laws. While some of these laws have been on the books for several years, the impact on employers and company policies are still evolving. This issue has created confusion for federal contractors who are required to compl...

Read More

Could a unique new fungus offer an opioid alternative? COULD A UNIQUE NEW FUNGUS OFFER AN OPIOID ALTERNATIVE?

blog article

Oct 17, 2019

A new fungus discovered in the estuarine waters of Tasmania could be the unexpected answer to the world's opioid crisis, a current study suggests. Opioids — many of which are prescription painkillers, such as codeine — have created a worldwide health crisis. Many opioids are highly a...

Read More

What Are the Benefits of CBD? WHAT ARE THE BENEFITS OF CBD?

blog article

Oct 16, 2019

The CBD industry is flourishing, conservatively projected to hit $16 billion in the United States by 2025. Already, the plant extract is being added to cheeseburgers, toothpicks and breath sprays. More than 60 percent of CBD users have taken it for anxiety, according to a survey of 5,000 people, con...

Read More

Which big pharma firms are best at digital? WHICH BIG PHARMA FIRMS ARE BEST AT DIGITAL?

blog article

Oct 16, 2019

New research by The Worldcom Public Relations Group has ranked pharmaceutical companies according to their usage of digital channels – with Bayer, Pfizer and Boehringer Ingelheim coming out on top. However, the report – called the Digital Health Monitor – also notes that many large...

Read More

Maintaining pharmaceutical manufacturing facilities MAINTAINING PHARMACEUTICAL MANUFACTURING FACILITIES

blog article

Oct 16, 2019

The best ways to keep your facility clean. Pharmaceutical facilities, especially those manufacturing biological products or sterile dosage forms, present considerable cleaning challenges. They must be: designed to be cleanable and maintained, tested for cleanliness, and cleaned thoroughly.

Read More

Five things for pharma marketers to know FIVE THINGS FOR PHARMA MARKETERS TO KNOW

blog article

Oct 15, 2019

Almost all patients with the vaping-related illness have ended up hospitalized, according to the Centers for Disease Control and Prevention. About half of people with the lung illness end up in the intensive care unit. Twenty-six people have died from the disease, and nearly 1,300 people have gotten...

Read More

DIY drugs: should hospitals make their own medicine? DIY DRUGS: SHOULD HOSPITALS MAKE THEIR OWN MEDICINE?

blog article

Oct 15, 2019

When a pharmaceutical company raised the price of an essential medicine to unacceptable levels, there was only one thing for pharmacist Marleen Kemper to do: start making it herself. When Kemper was in primary school, she had watched two of her classmates get ill. One had a brain tumour, the other c...

Read More

Clinical genetics: a part of Pharma’s DNA CLINICAL GENETICS: A PART OF PHARMA’S DNA

blog article

Oct 14, 2019

Genetic testing has become an increasingly buoyant area for deal making in recent years. While the pharma industry has been experiencing price pressure and low R&D productivity, the recent market ambition for “Precision Medicine”1 has driven interest and growth in clinical genetics a...

Read More

Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection WHY FOLLOW-ON PHARMACEUTICAL INNOVATIONS SHOULD BE ELIGIBLE FOR PATENT PROTECTION

blog article

Oct 14, 2019

Despite the important role of intellectual property rights in incentivizing innovation, the patenting of pharmaceutical innovation is frequently accused of impeding access to medicine. Criticism of the prevailing patent regime has focused in particular on patents directed towards follow-on pharmaceu...

Read More

IoT and Drug Adherence: Different Approaches to Connected Solutions IOT AND DRUG ADHERENCE: DIFFERENT APPROACHES TO CONNECTED SOLUTIONS

blog article

Oct 11, 2019

Sometimes it’s the really small things that make a huge difference to a person’s health. Skipping dosages of prescription medication, for example, has been linked to an array of negative effects. About half of us are guilty of not taking medication correctly, according to figures shared ...

Read More

DRUG PRICES KILLING OR DISEASES? DRUG PRICES KILLING OR DISEASES?

blog article

Oct 10, 2019

The United States is a huge economy and the economies look up to it for inspiration on how to manage the country to yield maximum output from the economy. But the medicines and drugs in the country are something that has always been on the controversial aspects of the country.

Read More

My pharmacy preregistration training provider wasn MY PHARMACY PREREGISTRATION TRAINING PROVIDER WASN'T UP TO SCRATCH

blog article

Oct 10, 2019

Pharmacist preregistration trainees are full-time employees, so they need to adjust to a new work environment, study for the registration assessment and juggle their everyday commitments. The preregistration year is stressful, but for hard-working and disciplined individuals, it pays off. And in ret...

Read More

Method “Matches” Medicines to Their Unique Protein Receptors METHOD “MATCHES” MEDICINES TO THEIR UNIQUE PROTEIN RECEPTORS

blog article

Oct 10, 2019

A receptor (drug target) can shift from a single subunit to a multi-structure in the presence of a ligand (drug compound) – a process known as "oligomerization". Having a method to determine exactly how different drug compounds target the same receptor is key to understanding why and...

Read More

Improving medicines safety as a volunteer pharmacist in Cambodia IMPROVING MEDICINES SAFETY AS A VOLUNTEER PHARMACIST IN CAMBODIA

blog article

Oct 09, 2019

Cambodia remains one of the poorest countries in the world following the devastating activities of the Khmer Rouge regime of the 1970s, and the standard of its health care is variable. In 2018, I spent two weeks scoping out potential opportunities to improve patient safety at a provincial hospital i...

Read More

Solar for Business: Pharmaceuticals SOLAR FOR BUSINESS: PHARMACEUTICALS

blog article

Oct 09, 2019

The healthcare industry’s core mission is to lengthen and improve lives. Because human health is inextricably linked to the health of the environment, pharmaceutical companies can further reinforce this mission through sustainable practices. While researchers work to develop innovative medical...

Read More

Shortage of drugs having a serious impact on primary care SHORTAGE OF DRUGS HAVING A SERIOUS IMPACT ON PRIMARY CARE

blog article

Oct 07, 2019

According to information gleaned from a drug tracker, more than 100 drugs regularly prescribed by GPs are now out of stock, and this is forcing patients to ‘chop and change’ between medicines. The tracker showed that a total of 106 products were unavailable earlier this month, while a fu...

Read More

Demonstrating drug potency early in cell therapy development DEMONSTRATING DRUG POTENCY EARLY IN CELL THERAPY DEVELOPMENT

blog article

Oct 07, 2019

With traditional drug development, the FDA typically focuses the majority of its attention on clinical aspects of a drug. With advanced cell and gene therapies, the agency places far more focus on chemistry manufacturing and controls (CMC) much earlier in development. Due in part to the fact that th...

Read More

Technology Towards an Efficient Monitoring of Clinical Trials TECHNOLOGY TOWARDS AN EFFICIENT MONITORING OF CLINICAL TRIALS

blog article

Oct 04, 2019

Clinical Study and Technology are two such genres that are progressing at a rapid rate. The implementation of age old practices does not suffice in any of the scenarios. Clinical trials are common in pharmaceutical industries and they occupy a major part in the approval of a drug. If the process of ...

Read More

Critical Strategies For Developing Your Pharma Team CRITICAL STRATEGIES FOR DEVELOPING YOUR PHARMA TEAM

blog article

Oct 04, 2019

Effective teamwork is crucial for any pharmaceutical company. Whether it's an outstanding sales manager, establishing the company’s brand, or a medical advisor, managing clinical trials by company guidelines, everyone on your team needs to be engaged and focused on the same goals to facili...

Read More

Pharma marketing’s evolving relationship with AI PHARMA MARKETING’S EVOLVING RELATIONSHIP WITH AI

blog article

Oct 02, 2019

How does artificial intelligence (AI) rank in the minds of pharmaceutical executives? How important is it in their eyes, and how does it compare to other trends? Although the buzz around AI has never been bigger, that’s not to say that every leader in pharma has bought into the hype yet. The D...

Read More

Researchers Have Developed Lab-Made THC and CBD RESEARCHERS HAVE DEVELOPED LAB-MADE THC AND CBD

blog article

Oct 02, 2019

When you smoke, vape, or eat cannabis, you obtain the cannabinoids THC and CBD from any of the thousands of different strains of cannabis plants. Until now, this was really the only way to get those cannabinoids, and trust me, it worked great. But a recent announcement from a man who knows more abou...

Read More

The market for unborn children: Big Pharma, vaccines and trafficking of aborted fetuses THE MARKET FOR UNBORN CHILDREN: BIG PHARMA, VACCINES AND TRAFFICKING OF ABORTED FETUSES

blog article

Oct 01, 2019

American family clinics, such as the Planned Parenthood Institute, first help women stop pregnancy . And immediately after, with half-closed doors, a very profitable journey begins. The aborted fetus is dissected in different parts, liver, kidney, thyme, skin, which are sold. A liver can cost up to ...

Read More

Why is biosimilar adoption slow in the U.S., and can something be done to boost uptake? WHY IS BIOSIMILAR ADOPTION SLOW IN THE U.S., AND CAN SOMETHING BE DONE TO BOOST UPTAKE?

blog article

Oct 01, 2019

Since the Hatch-Waxman Act of 1984 created an abbreviated regulatory approval pathway for generic pharmaceutical drugs in the U.S., generics have made tremendous strides in bringing down the cost of many medical treatments and even come to dominate some therapeutic areas.

Read More

95% of people think they could develop dementia with age 95% OF PEOPLE THINK THEY COULD DEVELOP DEMENTIA WITH AGE

blog article

Sep 30, 2019

A global study on attitudes toward dementia has shown that two-thirds of people believe it to be a natural risk of getting older, which could be limiting the help that people seek. Every 3 seconds, someone develops dementia somewhere in the world. In the United States alone, 5.8 million people are l...

Read More

What’s been stopping the pharma industry from true RIM transformation? WHAT’S BEEN STOPPING THE PHARMA INDUSTRY FROM TRUE RIM TRANSFORMATION?

blog article

Sep 30, 2019

The long-hoped for regulatory information management (RIM) transformation has yet to be achieved. As Steve Gens and John Cogan note in their recent paper — The Promise of Enterprise RIM – What’s Slowing the Innovation Potential? – the conversation all-too-often turns to issue...

Read More

Measure Patient Experience in Clinical Trials: It’s the right thing to do! MEASURE PATIENT EXPERIENCE IN CLINICAL TRIALS: IT’S THE RIGHT THING TO DO!

blog article

Sep 27, 2019

Forward-thinking Pharma companies recognize that when evaluating ROI on the patient experience, they need to think beyond finances. PX impacts trust in the brand and reputation in the industry. In the context of the recent Gallup poll on consumer perceptions where the pharma industry rated below ele...

Read More

Leveraging Advanced Analytics in the Pharmaceutical Industry LEVERAGING ADVANCED ANALYTICS IN THE PHARMACEUTICAL INDUSTRY

blog article

Sep 27, 2019

“Without a doubt, leveraging advanced analytics presents a real and significant opportunity for the pharmaceutical industry,” reports McKinsey in a 2018 article. Pharmaceutical companies know this, they just don’t know how to achieve and quantify business impact beyond hiring the d...

Read More

How will technology aid an ageing world? HOW WILL TECHNOLOGY AID AN AGEING WORLD?

blog article

Sep 26, 2019

This article explores the potential of readily available technology to address current traceability challenges as well as more wide-ranging issues in the pharmaceutical industry. According to Ernst and Young,1 the expected lifespan of someone born in 2015 will be more than 10 years longer than one b...

Read More

The 10 latest FDA Orphan Drug Designations for cancer treatments THE 10 LATEST FDA ORPHAN DRUG DESIGNATIONS FOR CANCER TREATMENTS

blog article

Sep 25, 2019

The FDA grants Orphan Drug Designation to treatments for rare diseases in R&D; here are the 10 most recent for oncologic conditions. The US Food and Drug Administration’s (FDA) Orphan Drug Designation (ODD) denotes medications that are potential promising treatments for rare diseases in th...

Read More

Could smart pill bottles dispense a solution to drug non-adherence? COULD SMART PILL BOTTLES DISPENSE A SOLUTION TO DRUG NON-ADHERENCE?

blog article

Sep 25, 2019

To tackle the challenge of medication adherence, particularly in the clinical trial space, UK health tech company Elucid has created a smart pill bottle and mobile app called Pill Connect. Currently in the trial stage, Pharma Tech Focus talks to Elucid’s CEO Dr James Burnstone about how the sy...

Read More

How does a drug for colorectal cancer work? HOW DOES A DRUG FOR COLORECTAL CANCER WORK?

blog article

Sep 25, 2019

Colorectal cancer is a fatal and common disease, and treatment decisions are often based on what genes have been mutated in the development of the cancer. This means that certain patients with colorectal cancer may benefit from the chemotherapeutic ‘cetuximab’ while other patients may be...

Read More

What is DXM? WHAT IS DXM?

blog article

Sep 24, 2019

A normal dosage of cough syrup has 15 to 30 milligrams of DXM. Most doctors recommend that you do not take more than 30 milligrams over a 24-hour period. It takes between 300 and 1,000 milligrams of DXM to get high. DXM can cause euphoria that ranges from a mild buzz to hallucination or an out-of-bo...

Read More

Reviving a Discontinued Drug REVIVING A DISCONTINUED DRUG

blog article

Sep 24, 2019

Most of the drugs that are taken off the market are removed for reasons other than safety. However, sometimes drug makers choose to remove drugs from the market even if there is no problem with their safety profile. In fact, from 1994 through 2015, 215 drugs were withdrawn from sale, and only 5.1 pe...

Read More

AI and Drug Discovery, Protecting the Value of Data in Collaborations AI AND DRUG DISCOVERY, PROTECTING THE VALUE OF DATA IN COLLABORATIONS

blog article

Sep 23, 2019

AI and Pharma update, Melloddy project—a ground-breaking collaboration between pharmaceutical companies, technology companies, and academic institutions to accelerate drug discovery by sharing pharmaceutical industry data. As we explained, the Melloddy project uses federated learning and block...

Read More

How a single payer system can help solve the US opioid crisis HOW A SINGLE PAYER SYSTEM CAN HELP SOLVE THE US OPIOID CRISIS

blog article

Sep 23, 2019

The US now has only a decade to achieve both universal health coverage and to prevent and treat substance abuse under the United Nations’ 2030 Sustainable Development Goals. Katherine Pettus argues that adopting a single-payer public health system is likely to be the only way to achieve these ...

Read More

How attractive are Bio-similars for pharma companies? HOW ATTRACTIVE ARE BIO-SIMILARS FOR PHARMA COMPANIES?

blog article

Sep 20, 2019

Biosimilar therapies are copies of large-molecule, biologic drugs. They differ from generics in that they are not exact copies of the original drug but, rather, a similar molecule that delivers an equivalent clinical outcome to the branded drug. Where small molecule drugs comprise 10s of atoms, biol...

Read More

Immigrants Buying Meds on the Street: A Problem of High Drug Prices and Fears of Deportation IMMIGRANTS BUYING MEDS ON THE STREET: A PROBLEM OF HIGH DRUG PRICES AND FEARS OF DEPORTATION

blog article

Sep 20, 2019

A lot of media coverage about counterfeit drug threats in the U.S. are spurred by the media relations efforts of organizations funded by pharmaceutical companies, such as the Alliance for Safe Online Pharmacies and Partnership for Safe Medicines. As I see it, their public education efforts conflate ...

Read More

BREXIT: WHAT IT MEANS FOR THE PHARMACEUTICAL INDUSTRY BREXIT: WHAT IT MEANS FOR THE PHARMACEUTICAL INDUSTRY

blog article

Sep 19, 2019

The UK is set to leave the European Union on October 31st, 2019, after extending the original deadline from the 29th March. Currently, there are ongoing discussions on whether we’ll have a deal in place or if a no withdrawal deal is agreed. Will the UK pharmaceutical industry be ready for Brex...

Read More

Zolgensma – more than just the world’s most expensive drug ZOLGENSMA – MORE THAN JUST THE WORLD’S MOST EXPENSIVE DRUG

blog article

Sep 19, 2019

The US Food and Drug Administration (FDA) recently approved Zolgensma, Novartis’ one-dose gene therapy for the treatment of paediatric patients (less than two years of age) suffering from spinal muscular atrophy (SMA), a rare but life-threatening disease. Zolgensma was acquired by Novartis as ...

Read More

The Enormous Potential of AI for Pharmaceutical THE ENORMOUS POTENTIAL OF AI FOR PHARMACEUTICAL

blog article

Sep 18, 2019

The adoption of Artificial Intelligence (AI) in research-intensive organizations has essentially seen linear growth in recent years. Pharmaceutical, CRO, university and healthcare organizations are beginning to shift away from theoretical plans to genuine practical applications of machine intelligen...

Read More

CBD MARKETING: HIGH MARKS FOR THE NEXT “IT” PRODUCT CBD MARKETING: HIGH MARKS FOR THE NEXT “IT” PRODUCT

blog article

Sep 18, 2019

CBD and products like it seem to be making an immediate splash in healthcare as of late.  But, how has this controversial product gained such rapid success?  Across the country more and more companies are popping up selling CBD products ranging from oils to dog treats.

Read More

Difference Between Opioids and Opiates DIFFERENCE BETWEEN OPIOIDS AND OPIATES

blog article

Sep 18, 2019

The difference between opioids and opiates is subtle enough that most people use the words interchangeably. After all, they both come from the poppy plant. The biggest difference is that opiates are natural drugs and opioids are synthetic drugs. They both have the same effect on the mind and can cau...

Read More

Building the smartest pharma company in the world BUILDING THE SMARTEST PHARMA COMPANY IN THE WORLD

blog article

Sep 17, 2019

The Finnish pharmaceutical company Orion Pharma, with help from Reaktor AI, has been on a journey to introduce AI into company operations across the board, to fully utilize all available data, and to build the capability to quickly adapt in an ever- changing world. In other words, their goal is to b...

Read More

Pharma Ecommerce: What It Takes To Win Online PHARMA ECOMMERCE: WHAT IT TAKES TO WIN ONLINE

blog article

Sep 17, 2019

The pharma ecommerce question doesn’t end with distributors. In fact, pharma manufacturers, too, must carve out a place in the digital ecosystem. So what can pharmaceutical manufacturers do to improve their customer experience through ecommerce? The article brought up a lot of great points, bu...

Read More

Key opinion leaders KEY OPINION LEADERS

blog article

Sep 16, 2019

Key Opinion Leaders (KOLs) are experts in their field and a respected voice in medical circles. They have an influential quality coveted by companies within the pharmaceutical industry. In this blog, we look at the role of KOLs and the 5 steps to creating an effective partnership. A KOL is typically...

Read More

Four stand-out skills you need to move into the pharma industry FOUR STAND-OUT SKILLS YOU NEED TO MOVE INTO THE PHARMA INDUSTRY

blog article

Sep 16, 2019

The pharmaceutical industry is an exciting, fast-paced and ever-changing world to work in. I talk to pharmaceutical sales professionals daily, from Graduate Sales Representatives promoting ‘me too’ drugs, to Senior Sales Directors working on specialist rare disease products, and have a s...

Read More

Why the Medical and Pharmaceutical Industries Need Great Process Piping Systems WHY THE MEDICAL AND PHARMACEUTICAL INDUSTRIES NEED GREAT PROCESS PIPING SYSTEMS

blog article

Sep 13, 2019

Medical and pharmaceutical manufacturers must adhere to strict sanitation standards and prioritize the safety of the products they create, regardless of production volume or costs. The U.S. Food and Drug Administration (FDA) strictly regulates the design, construction, and operation of medical and p...

Read More

US finds contaminant in popular heartburn drug US FINDS CONTAMINANT IN POPULAR HEARTBURN DRUG

blog article

Sep 13, 2019

U.S. health officials are investigating low levels of a potentially dangerous contaminant in the popular heartburn medication Zantac and related drugs. FDA officials said the amount of the contaminant barely exceeds levels found in common foods. But the same chemical has been linked to dozens of rec...

Read More

Medical writing - what is it? MEDICAL WRITING - WHAT IS IT?

blog article

Sep 12, 2019

This blog will give a brief insight into the discipline of medical writing, including the various types of writing and the skills deemed necessary by top medical writing companies. If you require high-quality scientific and medical writing services get in touch with Phil or Anna today - we are more ...

Read More

Your Cancer Targets May Not Be Real YOUR CANCER TARGETS MAY NOT BE REAL

blog article

Sep 12, 2019

A paper from Cold Spring Harbor labs that invalidated MELK as a cancer target. That was straightforward enough: knocking it out via CRISPR across a whole range of cancer cell lines had no effect on their growth at all, so it’s kind of hard to make the case that it’s an important thing to...

Read More

The Role of Sales in Sales Enablement THE ROLE OF SALES IN SALES ENABLEMENT

blog article

Sep 10, 2019

However, with a regular commute time that consumes a couple of hours each day, I have shifted my focus to podcasts and audiobooks. One of my favorite podcasts is the Inside Sales Enablement series by Scott Santucci and Brian Lambert. In their last episode, they spent time reviewing their thoughts an...

Read More

Implementing Buyer Enablement in Your Sales Enablement Strategy (2019) IMPLEMENTING BUYER ENABLEMENT IN YOUR SALES ENABLEMENT STRATEGY (2019)

blog article

Sep 10, 2019

The majority of the time I only had access to two TV channels, three on a good weather day, and I vividly remember when I first saw a color television. At this time, products and services were limited, and buyer choices were almost non-existent. Fast-forward to 2019. Not only do I have access to hun...

Read More

Drugs and their safety – an increasingly important subject in the pharmaceutical industry DRUGS AND THEIR SAFETY – AN INCREASINGLY IMPORTANT SUBJECT IN THE PHARMACEUTICAL INDUSTRY

blog article

Sep 10, 2019

Drug safety, also known as pharmacovigilance, refers to the systematic and continuous monitoring of the safety of a drug. The drugs are tested in order to identify and assess undesirable or even harmful effects for humans or animals. In order to protect patients, drugs must obtain official approval ...

Read More

Valuation of Pharma Companies: 5 Key Considerations VALUATION OF PHARMA COMPANIES: 5 KEY CONSIDERATIONS

blog article

Sep 10, 2019

Valuing pharma companies isn’t the same as valuing non-pharma companies, for several reasons. The life cycle of prescription drugs is relatively brief, with high-margin revenue falling to zero almost overnight when drug patents expire. Pharmaceuticals are high-growth, high-profit, and high-ris...

Read More

How a pharmaceutical company’s HIV research became immersive theater HOW A PHARMACEUTICAL COMPANY’S HIV RESEARCH BECAME IMMERSIVE THEATER

blog article

Sep 09, 2019

Four years ago, when ViiV Healthcare commissioned an ethnographic research study to understand the impact of HIV on black men in Baltimore and Jackson, Mississippi, the pharmaceutical company came away with a set of complex findings. Cultural identity, contextual environment, social structures and l...

Read More

The Future Of Pharma: Harnessing AI To Decentralise Data THE FUTURE OF PHARMA: HARNESSING AI TO DECENTRALISE DATA

blog article

Sep 09, 2019

Most tools and technologies that do advanced analytics or search, especially in pharma, force you to build a common repository for the data before any analytics can begin. This means one must invest in building something like a data warehouse or data lake first, then add your analytics engine on top...

Read More

It’s Time For Congress To Go All In On Drug Pricing Reform IT’S TIME FOR CONGRESS TO GO ALL IN ON DRUG PRICING REFORM

blog article

Sep 06, 2019

The partisan stars are appear to be aligned in Washington on passing federal drug pricing reform, but not without its share of political fits and starts. The latest proposal to suffer a setback has been Trump’s rebate rule, a clear signal that the Administration has pushed about as far as it c...

Read More

5 Steps to Social Media Strategy for Pharma 5 STEPS TO SOCIAL MEDIA STRATEGY FOR PHARMA

blog article

Sep 05, 2019

With almost 2.7 billion social media users worldwide it is vital that pharmaceutical companies form a social media strategy. Social media has transformed the way both consumers and companies communicate and has become the norm across other industries creating an expectation for consumers and patient...

Read More

Social media and the anti-vaccine movement SOCIAL MEDIA AND THE ANTI-VACCINE MOVEMENT

blog article

Sep 05, 2019

Vaccination as a public health intervention has significantly improved the health and wellbeing of the public and drastically reduced the burden of infectious diseases globally. Millions of lives have been saved with the World Health Organization (The WHO) estimating that 2–3 million lives are...

Read More

New Alzheimer’s Vaccine May Show Promise. NEW ALZHEIMER’S VACCINE MAY SHOW PROMISE.

blog article

Sep 04, 2019

Many biotechs have aimed to resolve Alzheimer’s via a vaccine over recent years, only to call it off due to nasty side effects such as brain swelling. But this drug, which the company has dubbed UB-311, is offering hope after wrapping up a Phase 2a Clinical Study. Next, the drug will begin a 2...

Read More

The promise and pitfalls of serial femtosecond X-ray crystallography THE PROMISE AND PITFALLS OF SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY

blog article

Sep 04, 2019

A report from scientists at the Moscow Institute of Physics and Technology highlights the advantages and disadvantages of serial femtosecond X-ray crystallography. This article investigates the review, focusing on its role in drug development. The article delves into the reasons behind the researche...

Read More

5 Reasons Your Company Needs Account-Based Marketing 5 REASONS YOUR COMPANY NEEDS ACCOUNT-BASED MARKETING

blog article

Sep 03, 2019

Every company can benefit from account-based marketing, no matter your size or target market. These are our top 5 reasons why your company would benefit from incorporating ABM tactics into your marketing strategy. If you go to any marketing conference or presentation, chances are you’ll hear a...

Read More

WHAT ARE “COSMECEUTICALS”? WHAT ARE “COSMECEUTICALS”?

blog article

Sep 03, 2019

The term “cosmeceutical” has become popular in recent years to describe a cosmetic product that claims medicinal benefits. While those in the cosmetic industry use the term to advertise the ingredients and benefits of their products, the FDA does not legally recognize the term. According...

Read More

The promise and pitfalls of molecular testing in oncology THE PROMISE AND PITFALLS OF MOLECULAR TESTING IN ONCOLOGY

blog article

Aug 30, 2019

Great strides have been made in the diagnosis and treatment of cancer. However, a variety of challenges remain that frustrate both physicians and patients. Central to this is how to use the large amounts of genetic data now available. Dr Chris Gaj explores the challenges and potential consequences f...

Read More

Deal Or No Deal: How Brexit Is Impacting Pharma DEAL OR NO DEAL: HOW BREXIT IS IMPACTING PHARMA

blog article

Aug 30, 2019

At the time of writing, the United Kingdom (UK) is on its third deadline to leave the European Union (EU). What was deemed to be “the easiest trade deal in human history1” is now looking ever increasingly unlikely; and is beginning to cause anguish for not only the pharmaceutical industr...

Read More

Prescription 2020: Democratic Candidates And Drug Pricing PRESCRIPTION 2020: DEMOCRATIC CANDIDATES AND DRUG PRICING

blog article

Aug 29, 2019

Prescription drug pricing appears poised to be an important issue in the 2020 presidential election. Identified as Americans’ top health care priority for the new Congress in 2019, the rising cost of prescription drugs has occupied an increasingly prominent place in national discourse. Perhaps...

Read More

A Field Manual For The Battle Over HIV Prevention Drug Pricing A FIELD MANUAL FOR THE BATTLE OVER HIV PREVENTION DRUG PRICING

blog article

Aug 29, 2019

Pre-exposure prophylaxis (PrEP) an HIV prevention intervention consisting of a daily drug cocktail, quarterly HIV/sexually transmitted disease screening, and laboratory monitoring—has repeatedly been shown to be safe, effective, and cost-effective. Although US guidelines have recommended PrEP ...

Read More

How our pharmacist-led anticoagulation service saves more than 500 bed days per year HOW OUR PHARMACIST-LED ANTICOAGULATION SERVICE SAVES MORE THAN 500 BED DAYS PER YEAR

blog article

Aug 28, 2019

Patients who are receiving long-term anticoagulation and are due for surgery, or other invasive procedures, may need to have their anticoagulants stopped temporarily to allow the procedure to be performed safely. In some circumstances, interrupting anticoagulation for a defined period carries minima...

Read More

Why It’s So Difficult to Reduce Drug Prices WHY IT’S SO DIFFICULT TO REDUCE DRUG PRICES

blog article

Aug 28, 2019

Partly because it’s an election year and partly because, well, drugs can be expensive, the topic of drug pricing is a hot-button issue. Earlier this year, in February, seven pharmaceutical executives were grilled by the U.S. Senate Finance Committee over drug pricing. The tone was set by U.S. ...

Read More

Real World Evidence: A Pharma-evolution REAL WORLD EVIDENCE: A PHARMA-EVOLUTION

blog article

Aug 28, 2019

Smart devices and wearables are the norm of the day. We wake up in the morning to our watch reminding us of the number of steps to walk, the speed of our heart beats etc. The same watch vibrates if we are stationary at our work station, prompting us to move. There is a surge in health-related data g...

Read More

The advantages of modular over traditional construction for pharmaceutical cleanrooms THE ADVANTAGES OF MODULAR OVER TRADITIONAL CONSTRUCTION FOR PHARMACEUTICAL CLEANROOMS

blog article

Aug 26, 2019

When constructing a cleanroom, the first decision you’re faced with is whether to opt for traditional (civil) construction over modular panels. There are several important considerations you must factor before making this expensive investment.

Read More

Top Things to Consider Before Investing in Pharma Machinery TOP THINGS TO CONSIDER BEFORE INVESTING IN PHARMA MACHINERY

blog article

Aug 26, 2019

Investment in pharma machinery requires lots of finance and efforts. Hence, the process needs to be very careful and considerate. There are numerous options in terms of make and models. Choosing the right one is difficult whether you buy a first-hand or a used machine. This post helps you to select ...

Read More

Marijuana is getting more popular in America while cocaine declines MARIJUANA IS GETTING MORE POPULAR IN AMERICA WHILE COCAINE DECLINES

blog article

Aug 23, 2019

Illicit drug use lurks in the shadows one reason its difficult to study. But public health researchers pull together numbers from surveys, overdose records and other sources to look for trends in how much people spend on drugs, numbers of users and frequency of use that can help policy makers fight ...

Read More

Drug-Resistant Salmonella Linked to Overuse of Antibiotics in Cattle Farming DRUG-RESISTANT SALMONELLA LINKED TO OVERUSE OF ANTIBIOTICS IN CATTLE FARMING

blog article

Aug 23, 2019

The Centers for Disease Control and Prevention (CDC) warned Thursday of a drug-resistant strain of salmonella newport linked to the overuse of antibiotics in cattle farming. The strain sickened 255 people in 32 states between June 2018 and March 2019, leading to 60 hospitalizations and two deaths, t...

Read More

Can CBD be Used to Treat Drug Addiction? CAN CBD BE USED TO TREAT DRUG ADDICTION?

blog article

Aug 22, 2019

There is a growing debate over the statutory medical use of marijuana and cannabinoids. Whilst there have been documented successful uses of cannabis and its derivatives in a medical context, concerns remain about its short-term and long-term side-effects including potential drug dependency and the ...

Read More

Random Drug and Alcohol Testing With Precede RANDOM DRUG AND ALCOHOL TESTING WITH PRECEDE

blog article

Aug 22, 2019

Random Drug and Alcohol Testing can effectively detect substance abuse in the workplace, ultimately helping keep employees safe and healthy in the workplace. More and more companies are using Random Testing as a method of reducing workplace incidents, and as an extra precaution if experiencing an in...

Read More

Why a no-deal Brexit means more fake pharma WHY A NO-DEAL BREXIT MEANS MORE FAKE PHARMA

blog article

Aug 21, 2019

Medicines are the most common medical intervention used across the UK and Europe. Unfortunately, falsified or fake medicines are entering global supply chains and have become a leading public health concern worldwide. It is, therefore, vital that there are systems in place to stop the manufacturing ...

Read More

Creating Content That Improves CX: A Q&A with Lionbridge & Aprimo CREATING CONTENT THAT IMPROVES CX: A Q&A WITH LIONBRIDGE & APRIMO

blog article

Aug 21, 2019

Today’s brands face numerous challenges. They need to create a customized, excellent experience for each and every customer worldwide. To do that, they need to create high-quality, on-target content. They need to create that content quickly, effectively, and for audiences who speak multiple la...

Read More

Going Global 101: How Your Competition Can Be Your Best Resource GOING GLOBAL 101: HOW YOUR COMPETITION CAN BE YOUR BEST RESOURCE

blog article

Aug 20, 2019

Lace-up your sneakers and step up to the starting line: you’re ready to reach countless customers in new markets.  You’ve secured your spot in the Global Marketplace (whether by default or design).  But before you sprint away, take a good look around you. You are not alone in t...

Read More

FDA Sent These Warning Letters To Pharma/Device Companies FDA SENT THESE WARNING LETTERS TO PHARMA/DEVICE COMPANIES

blog article

Aug 20, 2019

We cover three drug warning letters, one issued to a compounding pharmacy, one device warning letter and one in the food area that is a ‘first of its kind’.  One of the drug warning letters is issued to a firm that recovered solvents that were used in the manufacture of the API of v...

Read More

Alzheimers drug reverses brain damage due to underage drinking ALZHEIMERS DRUG REVERSES BRAIN DAMAGE DUE TO UNDERAGE DRINKING

blog article

Aug 20, 2019

Duke researchers show that alcohol induced brain damage in adolescents can be reversed using a drug prescribed for Alzheimers. A drug used to slow cognitive decline in Alzheimers disease could reverse alcohol induced brain damage. Brain inflammation and neuron damage in rats exposed to alcohol durin...

Read More

Morally corrupt drug pricing policy hurts black LGBTQ community the most MORALLY CORRUPT DRUG PRICING POLICY HURTS BLACK LGBTQ COMMUNITY THE MOST

blog article

Aug 19, 2019

Lowering prescription drug prices was a rallying cry for politicians in last years midterm election, and people came out in droves to support candidates who promised action on this front. Drug pricing, as well as the broader issue of crippling health care costs, cuts across lines that divide liberal...

Read More

The Pharmacist’s Role on Immunization: What to Look For and Look Out For THE PHARMACIST’S ROLE ON IMMUNIZATION: WHAT TO LOOK FOR AND LOOK OUT FOR

blog article

Aug 19, 2019

Three times a year, the Advisory Committee on Immunization Practices (ACIP) meets to review the latest findings on the immunization front, adjusting preferred dosing schedules and making recommendations in terms of best clinical practices. In that regard, the pharmacist’s role on immunization ...

Read More

Benzer Vaccination Programs: Great Shots for Quality “One-on-One” Time with Your Pharmacist BENZER VACCINATION PROGRAMS: GREAT SHOTS FOR QUALITY “ONE-ON-ONE” TIME WITH YOUR PHARMACIST

blog article

Aug 19, 2019

Like the kick-off of the NFL in the fall, the flu season may still be months away, but it’s always a good idea to circle a date on your calendar for getting up-to-date with immunizations. That, of course, goes double if you’re aged 59-or-older. It’s never comforting news to learn t...

Read More

Prescription Omega-3 Fatty Acid Medications Effectively Lower High Triglycerides PRESCRIPTION OMEGA-3 FATTY ACID MEDICATIONS EFFECTIVELY LOWER HIGH TRIGLYCERIDES

blog article

Aug 19, 2019

Prescription omega-3 fatty acid medication reduces triglyceride levels by 20-30 Percent among the majority of people who require treatment for high triglyceride levels, according to a science advisory from the American Heart Association. “From our review of the evidence from 17 randomized, con...

Read More

5 POTENTIAL IMPACTS THE PHARMA INDUSTRY SHOULD BE PLANNING FOR 5 POTENTIAL IMPACTS THE PHARMA INDUSTRY SHOULD BE PLANNING FOR

blog article

Aug 19, 2019

The Pharmaceutical industry has an annual turnover of 41.8 billion pounds, providing 8.2 Percent of UK goods exported and collectively employing 113,000 people, and is thus a major contributor to the nations ability to care for an ageing population and support an uncertain economy. What challenges d...

Read More

DIVERSE VOICES STRENGTHEN BRAND CHARACTER DIVERSE VOICES STRENGTHEN BRAND CHARACTER

blog article

Aug 14, 2019

What character appears in the most films and television programs? Dracula? God? Santa Claus?  All of those make the top ten list, but none is the correct answer. Satan (or The Devil) is a character is more than 840 projects – more than any other character. If you limit the list to mortals...

Read More

CX IN THE AGE OF PRIVACY AND TRUST, PART 3: CAN WE (RE)BUILD TRUST? CX IN THE AGE OF PRIVACY AND TRUST, PART 3: CAN WE (RE)BUILD TRUST?

blog article

Aug 14, 2019

This is the third in a series of articles on creating, maintaining, and optimizing great customer experiences in the context of mounting concerns about privacy and increasingly strict regulations governing data processing. We address topics such as consent strategies, the role of trust, the elements...

Read More

Understanding and Removing the Barriers to Patient Retention UNDERSTANDING AND REMOVING THE BARRIERS TO PATIENT RETENTION

blog article

Aug 14, 2019

Each year, 1.89 billion dollars is spent on patient recruitment for clinical trials.1 With a 30 Percent average dropout rate across all clinical trials, many pharmaceutical companies are spending a large amount of money to recruit patients who arent staying enrolled in their trials.

Read More

Bio-Inspired Nanomedicine An Emerging Trend For Drug Targeting Into Cancer Cells BIO-INSPIRED NANOMEDICINE AN EMERGING TREND FOR DRUG TARGETING INTO CANCER CELLS

blog article

Aug 14, 2019

The mortality rate increases day-to-day due to most vulnerable disease cancer universally and current therapeutic mitigation bears high levels of diversity and complexity in therapeutic regime. The systemic application of chemotherapeutic agents often accompanied with serious side and adverse effect...

Read More

Authorized Generics Explained AUTHORIZED GENERICS EXPLAINED

blog article

Aug 13, 2019

DRUGMAKERS LATEST GAMBIT EXPLAINED: DESIGNED TO EXTEND MARKET EXCLUSIVITY AND STIFLE OR DELAY COMPETITION, AUTHORIZED GENERICS CAN BE MORE PROFITABLE THAN BRAND. In 1984, the Hatch-Waxman Act established the modern generic drug business by establishing rules for safety and competition, including gra...

Read More

Sleep And Caffeine SLEEP AND CAFFEINE

blog article

Aug 13, 2019

Sleep and Caffeine are an epidemic, and it all starts when you wake up at 6:00 am and have a cup of coffee to start your day. Half way through your shift, you feel a bit sluggish so you have another. It’s the end of your shift, and you just need a little boost to get home and do the dishes, so...

Read More

The Warning Signs of Alcohol Addiction THE WARNING SIGNS OF ALCOHOL ADDICTION

blog article

Aug 12, 2019

The prevalence of alcohol-related driving fatalities is also well-documented. The NSDUH reported almost 10,000 such deaths in 2014, accounting for 31 Percent of all driving fatalities that year. And traffic deaths are just one of the potential life-threatening outcomes of alcohol overconsumption. Ac...

Read More

Drug Testing in the Workplace DRUG TESTING IN THE WORKPLACE

blog article

Aug 12, 2019

Drug testing can be quite a difficult and time-consuming policy to establish. Remember, an organisation must have consent from its employees to test them for drugs. This consent is usually included in the individual’s contract. The law imposes various requirements on employers who wish to unde...

Read More

Party Drug vs. Medical Success PARTY DRUG VS. MEDICAL SUCCESS

blog article

Aug 09, 2019

For one, the price. Having been around for decades, Ketamine wasnt expensive. Second, Ketamines effect was unique, unlike the highs-lows of previous party drugs, Ketamine created a physical and psychological dissociation from self. Given its low price and unique effect, Ketamine instantaneously beca...

Read More

Six ways to survive working as an on-call pharmacist SIX WAYS TO SURVIVE WORKING AS AN ON-CALL PHARMACIST

blog article

Aug 08, 2019

Working on call could be one of the most stressful parts of a pharmacists career, but it is also an essential part of a junior pharmacists training and a time during which you can learn the most. Clinical learning is at the forefront of most junior pharmacists minds, but it is the operational learni...

Read More

Adoption of closed loop medicines administration into the NHS ADOPTION OF CLOSED LOOP MEDICINES ADMINISTRATION INTO THE NHS

blog article

Aug 08, 2019

Closed loop medicines administration (CLMA) is the functionality that supports the cross checking of the correct patient, medicine and prescription using digital technologies. Specifically, checking should be used to confirm the patient identity against the medicine/dose due and the actual medicine ...

Read More

AI Drug Discovery Consortium Joins Forces with NVIDIA AI DRUG DISCOVERY CONSORTIUM JOINS FORCES WITH NVIDIA

blog article

Aug 08, 2019

Pharmaceutical companies have traditionally kept their data close to the vest because collaborations side effects may include compromising intellectual property and losing the edge over competitors. But sharing data has major perks. The more data a pharma company has at its disposal, the better equi...

Read More

How can technology improve the narrative for pharma? HOW CAN TECHNOLOGY IMPROVE THE NARRATIVE FOR PHARMA?

blog article

Aug 07, 2019

The pharmaceutical and healthcare industries in the UK and across the world are facing a multitude of challenges. They are being challenged on how they differentiate themselves in a growing and crowded marketplace, how they engage with their audiences and how they remain innovative and relevant.

Read More

What is the future of Continuing Medical Education CME? WHAT IS THE FUTURE OF CONTINUING MEDICAL EDUCATION CME?

blog article

Aug 07, 2019

In today’s knowledge-based society, health care professionals (HCPs) have a responsibility to continuously develop and refine their skills through lifelong learning. Academic institutes can foster such learning through programmes of continuing medical education (CME). But what is CME and why i...

Read More

Why Are Patients Facing Higher Costs When They Go to the Pharmacy? WHY ARE PATIENTS FACING HIGHER COSTS WHEN THEY GO TO THE PHARMACY?

blog article

Aug 05, 2019

BIO is out with a new whiteboard video that explores why more and more patients are facing higher costs when they go to the pharmacy to buy their prescription drugs. See how rebates and discounts within the drug cost ecosystem are often not used by insurers to lower patients out-of-pocket drug costs...

Read More

Responsibilities under the Drug Supply Chain Security Act- Is your pharmacy compliant? RESPONSIBILITIES UNDER THE DRUG SUPPLY CHAIN SECURITY ACT- IS YOUR PHARMACY COMPLIANT?

blog article

Aug 02, 2019

Have you heard of the Drug Supply Chain Security Act, and do you realize how it is already impacting your pharmacy operation? This post kicks off a blog series  Preparing for Track and Trace that will help you understand the ins and outs of the legislation and what it means for your business.

Read More

PRECISION MEDICINE HAS A LONG WAY TO GO PRECISION MEDICINE HAS A LONG WAY TO GO

blog article

Aug 01, 2019

A human biospecimen is a potential font of biological data-data that when aggregated in enormous volumes and crunched by artificial intelligence drives the development of precision medicine. By analyzing genetic profiles of patients and tumors, and by matching mutations to targeted drugs, precision ...

Read More

Data-driven care: why pharmacy needs to get involved DATA-DRIVEN CARE: WHY PHARMACY NEEDS TO GET INVOLVED

blog article

Jul 31, 2019

In the UK, the NHS generates vast quantities of data, much of which remain unused or underused, despite the potential to drive better care. There are many reasons for poor use of data. One is poor interoperability; differing healthcare terminology can mean the same medicines are described in thousan...

Read More

New cancer treatment disguises drugs in fat NEW CANCER TREATMENT DISGUISES DRUGS IN FAT

blog article

Jul 30, 2019

Every two minutes someone in the UK is diagnosed with cancer. And there are a range of options when it comes to treatment. Frequently, though, chemotherapy drugs, designed to hit fast-growing cells like cancers are used. But not all rapidly-growing cells are cancerous, so there are inevitably side e...

Read More

Innovations in Drug Delivery System – Injectables INNOVATIONS IN DRUG DELIVERY SYSTEM – INJECTABLES

blog article

Jul 29, 2019

The biologics drug development has stimulated innovations in novel injectable drug delivery systems. The conventional intravenous I.V. formulation is not suitable for biologics delivery due to its high viscosity, higher dosage volume, higher molecule size, protein stability issues and the need for t...

Read More

Future of Pharma: Building the Right Environment for AI Success FUTURE OF PHARMA: BUILDING THE RIGHT ENVIRONMENT FOR AI SUCCESS

blog article

Jul 25, 2019

What does the future of pharma look like through the eyes of a technologists background? We were fortunate enough to find out at last month at our 2nd annual GNS Forum. Shahram Ebadollahi, PhD, MBA who is the Global Head of Data Science and AI at Novartis AG, joined us to share his thoughts on how t...

Read More

Pharmalittle: New records show drug makers opioid push PHARMALITTLE: NEW RECORDS SHOW DRUG MAKERS OPIOID PUSH

blog article

Jul 24, 2019

Rise and shine, everyone, the middle of the week is already here. And a hazy, muggy morning is unfolding here on the Pharmalot campus this morning, where the officials mascot is noisily snoozing and one of the short people is sleeping in. As for us, we are downing yet another needed cup of stimulati...

Read More

Sanofi Strikes Deal for U.S. Over-the-Counter Rights to Roches Tamiflu SANOFI STRIKES DEAL FOR U.S. OVER-THE-COUNTER RIGHTS TO ROCHES TAMIFLU

blog article

Jul 23, 2019

France-based Sanofi struck a deal for the over-the-counter rights to Roches Tamiflu. The company will now be responsible for seeking approval from the U.S. Food and Drug Administration to sell the flu treatment without a prescription.

Read More

Circuit Denies “Pharma Bro” Martin Shkreli’s Appeal of His Conviction and District Court’s Forfeiture Order CIRCUIT DENIES “PHARMA BRO” MARTIN SHKRELI’S APPEAL OF HIS CONVICTION AND DISTRICT COURT’S FORFEITURE ORDER

blog article

Jul 22, 2019

On July 18, 2019, the Second Circuit issued a summary order in United States v. Shkreli (Jacobs, Livingston, Bianco) affirming the conviction and sentence of Martin Shkreli after his highly publicized 2017 trial in which he was convicted on two counts of securities fraud and one count of conspiracy ...

Read More

Dark History of Bayer Crop Science DARK HISTORY OF BAYER CROP SCIENCE

blog article

Jul 21, 2019

Bayer AG is a German chemical and pharmaceutical company that was founded in 1863 by Friedrich Bayerand Johann Wescott in Barmen, Germany. The company is one of the largest producers of aspirin and enjoys selling variety of medications for diabetes, birth control and multivitamins. Although recently...

Read More

Google AI Could Challenge Big Pharma in Drug Discovery GOOGLE AI COULD CHALLENGE BIG PHARMA IN DRUG DISCOVERY

blog article

Jul 21, 2019

A win for DeepMind, the AI arm of Google’s parent Alphabet, at a biennial biology conference could upend how drugmakers find and develop new medicines, according to Bloomberg. It could also dial up pressure on the world’s largest pharmaceutical companies to prepare for a technological ar...

Read More

The Latest on Drug Patent Scams THE LATEST ON DRUG PATENT SCAMS

blog article

Jul 19, 2019

HOW BIG PHARMA’S ANTI-COMPETITIVE PRACTICES DRIVE UP COSTS FOR EVERYBODY, WHILE AT THE SAME TIME STIFLING THE R & D THAT HIGH DRUG PRICES ARE SUPPOSED TO FUND. By now, most Americans understand that generic drugs and other biosimilars are not only safe, but tried-and-true. About three-quar...

Read More

Takeda Eyes Additional Divestitures to Pare Down Shire Deal Debt TAKEDA EYES ADDITIONAL DIVESTITURES TO PARE DOWN SHIRE DEAL DEBT

blog article

Jul 18, 2019

At the beginning of 2019, Takeda Pharmaceutical announced plans to sell about $10 billion worth of assets to offset some of the debt the company garnered in its $62 billion acquisitionof Shire. In May, the company sold off assets worth $5.7 billion and now, the company is looking to sell more.

Read More

Bayer, Bristol-Myers Squibb and Ono Pharma Team on Colorectal Cancer BAYER, BRISTOL-MYERS SQUIBB AND ONO PHARMA TEAM ON COLORECTAL CANCER

blog article

Jul 18, 2019

Bayer, Bristol-Myers Squibb and Ono Pharmaceutical have teamed up to study the most common type of metastatic colorectal cancer (mCRC). The three companies will collaborate to test Bayer’s kinase inhibitor Stivarga (regorafenib) and Bristol-Myers Squibb’s and Ono’s anti-PD-1 checkp...

Read More

Need for Patient Engagement in Pharma Today NEED FOR PATIENT ENGAGEMENT IN PHARMA TODAY

blog article

Jul 18, 2019

Pharmaceutical and clinical industries are facing fierce demands from insurers, regulators, independent groups and consumers every day. In order to improve clinical trials and the drug discovery process, it is important to build better communication and links between all the stakeholders. This means...

Read More

Why AI Is a Practical Solution for Pharma WHY AI IS A PRACTICAL SOLUTION FOR PHARMA

blog article

Jul 18, 2019

Artificial intelligence, or AI, is gaining more attention in the pharma space these days. At one time evoking images from futuristic science fiction, it now plays a significant role in smartphones, cars, search engines, and financial transactions. But what, exactly, is artificial intelligence? It is...

Read More

THE 7 PRINCIPLES OF PHARMA CONTENT THE 7 PRINCIPLES OF PHARMA CONTENT

blog article

Jul 17, 2019

In pharma, the sales process often starts with content, or a relationship may have started with some form of content. Great pharma content marketing follows a set of connected principles. Content marketing is the building of a narrative that looks to speak to target audiences, segments and personas ...

Read More

Why global medical communications need expert medical translations WHY GLOBAL MEDICAL COMMUNICATIONS NEED EXPERT MEDICAL TRANSLATIONS

blog article

Jul 17, 2019

Medical communications can be challenging, even in English, as they often contain highly technical terminology which has to be clinically accurate and precise. When your communications need to engage and educate audiences on a global scale, it can be even more challenging. Medical translations requi...

Read More

What Pharma Companies Must Do Globally to Benefit From Canada’s Patent Term Extension Framework WHAT PHARMA COMPANIES MUST DO GLOBALLY TO BENEFIT FROM CANADA’S PATENT TERM EXTENSION FRAMEWORK

blog article

Jul 17, 2019

Canada implemented its patent term extension program, the Certificate of Supplementary Protection (CSP) framework, on September 21, 2017.  The CSP regime is beneficial to qualifying pharmaceutical product developers because it can add up to two additional years of patent protection.  Notab...

Read More

Why Attending a Pharma Bio Conference Can Help Your Career WHY ATTENDING A PHARMA BIO CONFERENCE CAN HELP YOUR CAREER

blog article

Jul 17, 2019

You lead a busy life and have a busy schedule. Attending a pharmaceuticals or biotech industry conference requires time and resources, which are often in short supply. But carving out the few days and committing the funds can make a huge difference when you’re looking to grow professionally.

Read More

Ruling Reversed on Prescription Drug Rebate RULING REVERSED ON PRESCRIPTION DRUG REBATE

blog article

Jul 16, 2019

The White House has reversed its ruling from earlier this year that would have amended the safe harbor regulations eliminating traditional rebates and requiring discounts be moved to the point-of-sale. The ruling was designed to decrease the overall cost of drugs and lower the out-of-pocket cost bur...

Read More

FDA Sent These Warning Letters To Pharma/Device Companies. FDA SENT THESE WARNING LETTERS TO PHARMA/DEVICE COMPANIES.

blog article

Jul 16, 2019

There were six warning letter postings during this week: three drug warning letters including one regarding Akorn’s site in Somerset, NJ that the company announced a few weeks ago, one to a device manufacturer, one to an IRB, and one to a compounding pharmacy.

Read More

CANNABIS STOCKS BLAZE AS FDA EXPEDITES LANDMARK CBD RULES CANNABIS STOCKS BLAZE AS FDA EXPEDITES LANDMARK CBD RULES

blog article

Jul 16, 2019

Cannabis stocks got a boost this week after the US Food and Drug Administration announced it would expedite creating a regulatory framework for CBD. CBD is the non-psychoactive ingredient in cannabis, which allegedly has wellness properties, and can treat a range of various conditions, including pai...

Read More

Mixing Medicines Can Be Dangerous MIXING MEDICINES CAN BE DANGEROUS

blog article

Jul 15, 2019

Prescription and over-the-counter (OTC) medicines are tested to make sure they’re safe and effective. But if you mix those drugs with other medicines or substances—intentionally or even by accident—they can have potentially dangerous effects.

Read More

Hartman vs Pfizer Wrongful Death Lawsuit HARTMAN VS PFIZER WRONGFUL DEATH LAWSUIT

blog article

Jul 15, 2019

One of the most famous wrongful death lawsuits is the Hartman versus Pfizer Hollywood lawsuit which occurred in the early 1990s. In 1998, Phil Hartman, a well-known comedian and Saturday Night Live actor, was shot and killed by his wife, Brynn, who then turned the gun on herself and took her own lif...

Read More

Typical Management Styles in Pharma Industry TYPICAL MANAGEMENT STYLES IN PHARMA INDUSTRY

blog article

Jul 15, 2019

Pharma Veterans shares the wealth of knowledge and wisdom of Veterans for the benefit of Pharma Community. The next management style seen in Pharma Managers is ‘The Selfish Big Brother’. Of all the Big Brothers, the Selfish Big Brother is mostly a dangerous character. We have seen Big Br...

Read More

Trump Administration Withdraws Harmful Drug Rebate Safe Harbor Rule TRUMP ADMINISTRATION WITHDRAWS HARMFUL DRUG REBATE SAFE HARBOR RULE

blog article

Jul 15, 2019

On July 10, the Trump Administration announced that it would withdraw a proposed rule to eliminate the safe harbor in the federal anti-kickback law for rebates negotiated by pharmacy benefit managers (PBMs) on behalf of Medicaid managed care plans and Medicare Part D plans.  This is a highly we...

Read More

SailPoint Levels-Up their ABM Strategy with Intent Data SAILPOINT LEVELS-UP THEIR ABM STRATEGY WITH INTENT DATA

blog article

Jul 15, 2019

The buyer’s journey has changed in a way which leaves many sales and marketing teams struggling to find insight from within what we call the Dark Funnel. However, many technology companies are starting to build solutions to address the radical new way customers engage and buy today by collecti...

Read More

Duo Security Sets BDRs up for Success with 6sense DUO SECURITY SETS BDRS UP FOR SUCCESS WITH 6SENSE

blog article

Jul 15, 2019

The role of a Business Development Rep can be a daunting one. Knowing where to prioritize when you have over 1,000 accounts and knowing what content to reach out to them and engage them with can be an impossible task. But if you have the right intent data that can show you where the account is in th...

Read More

Nanoparticle-Based targeted Drug Delivery System NANOPARTICLE-BASED TARGETED DRUG DELIVERY SYSTEM

blog article

Jul 13, 2019

Nanomedicine and nano delivery systems are a relatively new but rapidly developing science where materials in the nanoscale range are employed to serve as means of diagnostic tools or to deliver therapeutic agents to specific targeted sites in a controlled manner. Nanotechnology offers multiple bene...

Read More

Demystifying Multichannel Measurement Across the Pharma Product Lifecycle DEMYSTIFYING MULTICHANNEL MEASUREMENT ACROSS THE PHARMA PRODUCT LIFECYCLE

blog article

Jul 12, 2019

Pharmas are growing more assured in their use of digital channels and are increasingly taking a robust multichannel approach to healthcare professional engagement, moving away from their traditional focus on direct sales. Even so, many brands continue to miss the mark with their multichannel HCP eff...

Read More

The End of an Era in Pharma THE END OF AN ERA IN PHARMA

blog article

Jul 12, 2019

National Health Commission has just released the first version of its monitoring catalogue for rational drug use. This is the first national-level policy aimed to curb “irrational drug use”; previous attempts have been trial runs at the provincial and municipal levels. The policy monitor...

Read More

The benefits of closed-loop marketing for pharma companies THE BENEFITS OF CLOSED-LOOP MARKETING FOR PHARMA COMPANIES

blog article

Jul 12, 2019

CLM has a huge impact on pharma companies, causing a major change in firm culture & ways of working, because of this new concept introduction. The idea is to create a virtuous circle between a target & a multi-channel digital marketing tool aimed for sales. CLM captures the Health Care Profe...

Read More

Real-World Evidence is What Pharma Needs Now to Help Cure Lung Cancer REAL-WORLD EVIDENCE IS WHAT PHARMA NEEDS NOW TO HELP CURE LUNG CANCER

blog article

Jul 11, 2019

Non-Small Cell Lung Cancer (NSCLC) is a designation that accounts for more than 80 percent of lung cancers diagnosed, and it has emerged as a new hotspot for investment by pharma manufacturers. Globally, the NSCLC therapeutics market is expected to rise to a valuation of US $15.1 billion by 2023, wi...

Read More

New drug promises to end migraine pain in two hours NEW DRUG PROMISES TO END MIGRAINE PAIN IN TWO HOURS

blog article

Jul 11, 2019

There are patients who do not respond to the available migraine medications. The drugs also have other limiters: the possibility of strong side effects and the prohibition of prescription for individuals with cardiovascular disease, since they constrict the blood vessels. Researchers at the Albert E...

Read More

How Does Pharma Learn to Speak Patient? The “Patient Voice” HOW DOES PHARMA LEARN TO SPEAK PATIENT? THE “PATIENT VOICE”

blog article

Jul 11, 2019

Before getting to the language of patients or “patient voice,” it is useful to understand that “we are not all patients.” Carolyn Thomas, writer and patient advocate, explains that, being a patient “sometime or other in life” is not the same thing as being a patie...

Read More

Buried Treasure – Of a Sort BURIED TREASURE – OF A SORT

blog article

Jul 10, 2019

A former colleague was telling me the other day about some not-so-pleasant surprises that occurred when he was helping to clean out a lab that hadn’t had some cabinets opened in a while, and I think many readers will have had such experiences. Academic labs are particularly prone to Easter egg...

Read More

WITH PRESCRIPTION PRICES ON THE RISE, THIS STARTUP IS SHAKING UP PHARMA FROM THE INSIDE OUT WITH PRESCRIPTION PRICES ON THE RISE, THIS STARTUP IS SHAKING UP PHARMA FROM THE INSIDE OUT

blog article

Jul 10, 2019

In 2017, U.S. healthcare spending grew 3.9 percent, reaching $3.5 trillion. On average, that’s more than $10,000 per person. Smaller employers are having a hard time keeping up with rising costs, causing many to move to high-deductible plans that shift the cost burden onto the employee, says R...

Read More

Pharmaceutical Packaging Solutions at Uhlman’s Pharmazing Days 2019 PHARMACEUTICAL PACKAGING SOLUTIONS AT UHLMAN’S PHARMAZING DAYS 2019

blog article

Jul 09, 2019

The 2019 Uhlman’s Pharmazing Days were held in June at Uhlmann’s headquarters in Laupheim, Germany.  Over 500 attendees visited, and over 20 exhibition partners showcased pharmaceutical packaging solutions that are integrated with Uhlmann’s systems.  Uhlmann Pac-Systeme s...

Read More

China CHINA'S PHARMACEUTICAL MARKET EXPECTED TO BOOM IN COMING YEARS

blog article

Jul 09, 2019

In a recent panel discussion at the World Economic Forum’s Annual Meeting of the New Champions, held in Dalian, China, ethicists and biotech executives met to discuss a plan for the future of biotech. One of the issues discussed was whether the new big breakthrough in the industry, and the dom...

Read More

PhRMA-backed Study Shows Hospitals Significantly Hike Drug Prices PHRMA-BACKED STUDY SHOWS HOSPITALS SIGNIFICANTLY HIKE DRUG PRICES

blog article

Jul 09, 2019

A study commissioned by Pharmaceutical Research and Manufacturers of America (PhRMA) revealed that hospitals across the United States typically charge five times more for medications than their costs. This results in an increase in cost-sharing and premiums for patients, the study found. The latest ...

Read More

First Generic Launch has Significant First-Mover Advantage Over Later Generic Drug Entrants FIRST GENERIC LAUNCH HAS SIGNIFICANT FIRST-MOVER ADVANTAGE OVER LATER GENERIC DRUG ENTRANTS

blog article

Jul 08, 2019

The first generic drug to make it to market after drug patent expiration enjoys a significant market share advantage over later arrivals. Furthermore, market share advantage – which can be up to 90% – holds for at least three years.

Read More

FOR AI-ENABLED DRUG DISCOVERIES, WHO OWNS THE SCIENCE? FOR AI-ENABLED DRUG DISCOVERIES, WHO OWNS THE SCIENCE?

blog article

Jul 08, 2019

Dealing with intellectual property issues presents a challenge, of sorts, for drug developers. The last in our series. There is no doubt that artificial intelligence is greatly influencing the field of drug discovery. For the past several days we’ve heard from a number of scientists, from the ...

Read More

Why Sales Leaders Need to Digitally Transform Their Teams WHY SALES LEADERS NEED TO DIGITALLY TRANSFORM THEIR TEAMS

blog article

Jul 08, 2019

Three key trends are driving the need for sales leaders to digitally transform their organizations. First, b-to-b buyers are conducting more of their purchase journey in the digital arena and demanding the same kind of frictionless and seamless customer experience they enjoy as consumers. Second, th...

Read More

The Most Important Metric for Sales Leaders in Subscription Businesses to Track and Use to Drive Revenue Growth THE MOST IMPORTANT METRIC FOR SALES LEADERS IN SUBSCRIPTION BUSINESSES TO TRACK AND USE TO DRIVE REVENUE GROWTH

blog article

Jul 08, 2019

Subscription businesses that charge customers monthly for using their offerings are expanding rapidly in response to consumers’ and b-to-b buyers’ desire to try a product and walk away easily if they’re not achieving the expected value. However, the subscription-based business mode...

Read More

Sweet Almonds: One Amino Acid Did the Trick SWEET ALMONDS: ONE AMINO ACID DID THE TRICK

blog article

Jul 08, 2019

Well, I spent the holiday weekend here sending out pictures of food on my Twitter account, so I suppose it’s only fitting that I blog about a related topic today. But it also touches on metabolic enzymes, transcription factors, and death by cyanide, so there’s something for most everyone...

Read More

Stephen Watkins: STEPHEN WATKINS: 'WHAT WE'RE DOING IS ABOUT TRANSFORMATION OF PHARMACY'

blog article

Jul 05, 2019

Despite the recent announcement that it plans to close 200 stores, Stephen Watkins, director of pharmacy items at Boots, promises that its ongoing digital transformation will be a game changer for the entire industry. As things stand, Boots likes to boast that 90% of the UK population are just ten m...

Read More

How to understand and interpret clinical data HOW TO UNDERSTAND AND INTERPRET CLINICAL DATA

blog article

Jul 05, 2019

This resource, part of the acute pain learning series, has been developed to help pharmacists understand the quality of evidence from clinical data to inform the advice they give to patients. Clinical data inform guidelines and practice, and are the foundation upon which evidence-based medicine rest...

Read More

Clinical guidelines and evidence base for acute pain management CLINICAL GUIDELINES AND EVIDENCE BASE FOR ACUTE PAIN MANAGEMENT

blog article

Jul 05, 2019

The variety of over-the-counter treatments and guidelines allows for misconceptions around the best self-care options for patients with acute pain. This article highlights when and why pharmacists should review the literature to support clinical decision making in patients presenting with symptoms o...

Read More

Hot Melt Extrusion in the Pharmaceutical and Food Industries HOT MELT EXTRUSION IN THE PHARMACEUTICAL AND FOOD INDUSTRIES

blog article

Jul 04, 2019

Hot melt extrusion is a manufacturing technique that was originally established in the early 1930s for use in the plastics and food industries but is now gaining popularity in the pharmaceutical industry as well. Around half of all plastics products are made using hot melt extrusion, which is the pr...

Read More

Excipients take center stage: the impact on formulations and compliance EXCIPIENTS TAKE CENTER STAGE: THE IMPACT ON FORMULATIONS AND COMPLIANCE

blog article

Jul 04, 2019

When you think of a medication, is the active ingredient the first thing that pops into your head, or perhaps the name of the drug? You’re not alone. The active ingredient of a medicine gets all the attention, which is fair, considering it’s what gives the medicine its therapeutic proper...

Read More

CMS Mandates Pharma to Disclose Drug Prices CMS MANDATES PHARMA TO DISCLOSE DRUG PRICES

blog article

Jul 04, 2019

If you are watching television in the United States, you are more than likely to see at least one drug commercial. These direct-to-consumer ads, as the industry knows them, offer brief testimonials of a drug’s effectiveness and safety, but typically leave out the drug’s price. As a bold ...

Read More

AMA Says Mature 12-Year-Olds Can Consent to Vaccination Without Parents AMA SAYS MATURE 12-YEAR-OLDS CAN CONSENT TO VACCINATION WITHOUT PARENTS

blog article

Jul 03, 2019

At the recently concluded annual meeting of the American Medical Association (AMA) in Chicago, AMA delegates adopted a doozy of a new policy. The powerful trade group agreed to develop model legislation that pressures state legislatures into allowing minors to "override refusenik parents on vac...

Read More

EU Approves Two-Drug Pill as First-Line Treatment for HIV EU APPROVES TWO-DRUG PILL AS FIRST-LINE TREATMENT FOR HIV

blog article

Jul 03, 2019

The two-drug pill Dovato, developed by the UK company ViiV Healthcare, has been approved as a first-line treatment for HIV, potentially causing fewer long-term side effects than current three-drug antiretroviral regimens. HIV patients currently need to take three or more antiretroviral drugs per day...

Read More

FDA Gives Nod To 1st Sinusitis Drug That Includes Nasal Polyps FDA GIVES NOD TO 1ST SINUSITIS DRUG THAT INCLUDES NASAL POLYPS

blog article

Jul 03, 2019

In what specialists have termed to a pivotal point, the FDA approved a chronic sinusitis drug, a disease which causes polyps in the sinuses. Names Dupixent, the injection is administered every 2 weeks. Those with chronic rhinosinusitis and nasal polyps will be treated with this drug. FDA stated that...

Read More

Booker returns campaign donation from pharmaceutical executive after slamming industry BOOKER RETURNS CAMPAIGN DONATION FROM PHARMACEUTICAL EXECUTIVE AFTER SLAMMING INDUSTRY

blog article

Jul 02, 2019

The check was from Eagle Pharmaceutical Executive Vice President and Chief Compliance Officer Michael Cordera. The Booker campaign said Cordera listed his occupation as “attorney” for the donation. "[Booker’s] presidential campaign rejects these contributions too, and we caref...

Read More

Public Comment to the WHO About Online Access to Imported Medicines and SDG 3.8 PUBLIC COMMENT TO THE WHO ABOUT ONLINE ACCESS TO IMPORTED MEDICINES AND SDG 3.8

blog article

Jul 02, 2019

One of the Sustainable Development Goals, 3.8, created under UN auspices is: “Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all....

Read More

10 Professionals Predict the Future of Clinical Trials 10 PROFESSIONALS PREDICT THE FUTURE OF CLINICAL TRIALS

blog article

Jul 02, 2019

Developing new drugs is a slow, costly and labor-intensive process, but cutting-edge technologies offer the promise of streamlining the process in a way that’s never been done before. The pharma industry is also approaching clinical trials in a more thoughtful and connected way, putting a grea...

Read More

Premier PREMIER'S PROVIDEGX TO LAUNCH INTRAVENOUS NUTRITION DRUG

blog article

Jul 02, 2019

Premier subsidiary ProvideGx is now supplying cysteine hydrochloride injections to its member providers, the generic-drug division of the group purchasing and consulting organization announced Tuesday. ProvideGx teamed up with the manufacturer Exela Pharma Sciences to deliver the only Food and Drug ...

Read More

Six drug-free treatment options for people with cognitive illnesses SIX DRUG-FREE TREATMENT OPTIONS FOR PEOPLE WITH COGNITIVE ILLNESSES

blog article

Jul 02, 2019

While cures may not currently be possible for many forms of cognitive illnesses, are there ways to treat people without the use of drugs? Some believe it is possible to help manage some of the challenging behaviors and symptoms with a number of drug-free treatment options, including holistic therapi...

Read More

The growing need for RegTech in the Pharmaceutical Industry THE GROWING NEED FOR REGTECH IN THE PHARMACEUTICAL INDUSTRY

blog article

Jul 02, 2019

We first witnessed the emergence of RegTech shortly after the economic plunge of 2008. The financial disaster spurred an increase in regulation in the finance and banking industries, and as a result, companies began to shell out billions in compliance costs. To stay compliant, while also working wit...

Read More

How we revolutionised care by giving everyone in our team an iPad HOW WE REVOLUTIONISED CARE BY GIVING EVERYONE IN OUR TEAM AN IPAD

blog article

Jul 02, 2019

All clinical pharmacists and pharmacy technicians were issued with iPads, to align with NUH’s vision to deliver ‘clinically-led, mobile-facilitated information and communication technology (ICT) as part of a paperless hospital by 2020’. That is easy to say, but it was a huge strugg...

Read More

Gut Bacteria, Pitching In GUT BACTERIA, PITCHING IN

blog article

Jul 02, 2019

When a patient takes an oral dose of a drug, you can picture it as being a little like one of the those Japanese pachinko machines, where a ball drops into a maze of complicated bouncing paths on its way to the bottom. There are a lot of things that happen once a pill hits the gut, the broad feature...

Read More

Why You Need to Start Thinking About Meaningful Differentiation Much Earlier WHY YOU NEED TO START THINKING ABOUT MEANINGFUL DIFFERENTIATION MUCH EARLIER

blog article

Jul 01, 2019

Pharma companies may have a winning asset, a winning development plan and an important disease target with unmet needs, but only one product can be first to market, only one can be the most efficacious and only one will become the standard of care. If your asset is entering a disease area with simil...

Read More

New Research Raises Possibility Of Better Anti-Obesity Drugs NEW RESEARCH RAISES POSSIBILITY OF BETTER ANTI-OBESITY DRUGS

blog article

Jul 01, 2019

Effective weight-loss strategies call for eating less food, burning more calories — or ideally, both. But for the more than 90 million Americans who suffer from obesity, a disease that contributes to conditions ranging from heart disease to cancer, behavioral change is hard to accomplish or no...

Read More

High Doses Of 60 Plus-Year-Old Chemo Drug Found To Spur Immune System Attack On Lymphoma HIGH DOSES OF 60 PLUS-YEAR-OLD CHEMO DRUG FOUND TO SPUR IMMUNE SYSTEM ATTACK ON LYMPHOMA

blog article

Jul 01, 2019

More than 60 years ago, British physician Denis Parsons Burkitt and his associates achieved one of the signal successes in cancer medicine when they cured children in sub-Saharan Africa with a form of lymphoma by treating them with high doses of the chemotherapy drug cyclophosphamide. Now, Dana-Farb...

Read More

6 Reasons Why Advanced Analytics Is Essential In Pharma 6 REASONS WHY ADVANCED ANALYTICS IS ESSENTIAL IN PHARMA

blog article

Jun 30, 2019

It’s no secret that technology has had a major impact not only on our daily activities, but also on businesses in almost every industry. The pharma industry, in particular, has seen major changes throughout many operations due to the implementation of technology. Technology such as Artificial ...

Read More

Is a diabetes drug the key to aggressive breast cancer? IS A DIABETES DRUG THE KEY TO AGGRESSIVE BREAST CANCER?

blog article

Jun 28, 2019

New research finds that the diabetes drug metformin changes stem cancer cells in a way that makes them easier to target with a new form of treatment. The findings could help treat triple-negative breast cancer, which is particularly aggressive.

Read More

Insulin: why the price of a 100-year-old drug has tripled in a decade INSULIN: WHY THE PRICE OF A 100-YEAR-OLD DRUG HAS TRIPLED IN A DECADE

blog article

Jun 26, 2019

Insulin prices have skyrocketed to the point where many people with diabetes live in insulin poverty, with one in four rationing their insulin and an even larger proportion trading off other life necessities (food, rent, clothing) to afford their insulin supply. The rise in insulin prices has nothin...

Read More

AbbVie, Allergan, Ugh ABBVIE, ALLERGAN, UGH

blog article

Jun 26, 2019

News broke yesterday morning (first at the Wall Street Journal, I believe) that Abbvie has agreed to acquire Allergan. This is one of the larger pharma mergers of recent years, and regular readers of this site will have a pretty good idea of the sigh and roll of the eyes with which I greet it. I thi...

Read More

Pharmacists: we can support people with alcohol issues PHARMACISTS: WE CAN SUPPORT PEOPLE WITH ALCOHOL ISSUES

blog article

Jun 26, 2019

The pharmacy profession is very good at talking to people about their medicines and, as experts in medicines, we keep up to speed with the latest guidance and evidence. Despite working through challenging climates, we aspire to be as holistic and patient-centred as possible. Alcohol dependency is a ...

Read More

A Streamlined Pathway to Drug Approval A STREAMLINED PATHWAY TO DRUG APPROVAL

blog article

Jun 26, 2019

Randomized, placebo-controlled clinical trials have long been the gold standard for drug approval. Patients are assigned to either drug or placebo and the comparison between the two groups can provide meaningful data to allow the Food and Drug Association (FDA), pharmaceutical companies, physicians,...

Read More

Bill allowing state lawyers access to doctors database of controlled substance users signed into Florida law BILL ALLOWING STATE LAWYERS ACCESS TO DOCTORS DATABASE OF CONTROLLED SUBSTANCE USERS SIGNED INTO FLORIDA LAW

blog article

Jun 26, 2019

A measure that would allow attorneys for the state to have access to a prescription-drug database as they pursue a lawsuit against the pharmaceutical industry over the opioid epidemic was among 10 bills signed Monday by Gov. Ron DeSantis. The signings nine were announced by the governor’s offi...

Read More

The More the Merrier: High Doses of Lilly THE MORE THE MERRIER: HIGH DOSES OF LILLY'S TRULICITY SHOW SUPERIORITY IN REDUCING WEIGHT AND A1C

blog article

Jun 26, 2019

Eli Lilly’s type 2 diabetes drug Trulicity hit the mark in a late-stage trial that showed higher doses of the medication significantly reduced A1C from baseline compared to the once-per-week dose of Trulicity currently on the market. Trulicity (dulaglutide) is currently approved for type 2 dia...

Read More

Acceleron Completes Target Enrollment in the PULSAR Phase 2 Trial of Sotatercept in Pulmonary Arterial Hypertension ACCELERON COMPLETES TARGET ENROLLMENT IN THE PULSAR PHASE 2 TRIAL OF SOTATERCEPT IN PULMONARY ARTERIAL HYPERTENSION

blog article

Jun 26, 2019

Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics to treat serious and rare diseases, announced today it has completed target enrollment of patients with pulmonary arterial hypertension (PAH) in the PULSAR P...

Read More

Independent Pharmacy Alliance of America (IPA) and Leading Edge Pharms Ink Deal to Bring Topical Hemp/CBD to Member Pharmacies INDEPENDENT PHARMACY ALLIANCE OF AMERICA (IPA) AND LEADING EDGE PHARMS INK DEAL TO BRING TOPICAL HEMP/CBD TO MEMBER PHARMACIES

blog article

Jun 26, 2019

Leading Edge Pharms, Inc. (www.leadingedge.com), a biotechnology company developing novel cannabinoid therapies and innovative delivery platforms, today announced its partnership with Independent Pharmacy Alliance (https://www.ipa-rx.org/), a trade group and retail pharmacy buying cooperative, to ma...

Read More

High Drug Prices Stoke Congress’ Ire HIGH DRUG PRICES STOKE CONGRESS’ IRE

blog article

Jun 25, 2019

Democrats and Republicans in Congress have found common ground when it comes to the issue of exorbitant prescription drug prices.  Both agree some measure of market-based reform is needed to alleviate the burden on individual patients and on hospitals from rising drug prices, shortages of criti...

Read More

Trends in Oncology Clinical Trials TRENDS IN ONCOLOGY CLINICAL TRIALS

blog article

Jun 25, 2019

Cancer continues to present new challenges and opportunities for pharmacologic intervention. Accordingly, the pharmaceutical industry continues to pursue the development of cancer drugs at an unparalleled rate. Three major trends have emerged over the last several years to fuel this pursuit.

Read More

Drug testing helps secure safer workplace DRUG TESTING HELPS SECURE SAFER WORKPLACE

blog article

Jun 24, 2019

Employers committed to safety are continuing to follow best practices for maintaining a drug-free workplace, despite recent changes in employee drug testing laws. Surveys show drug abuse in the U.S. population has expanded in recent years, and it’s not something that impacts people only on the...

Read More

ASCO 2019: The future of Keytruda plus chemo combination therapy ASCO 2019: THE FUTURE OF KEYTRUDA PLUS CHEMO COMBINATION THERAPY

blog article

Jun 24, 2019

As the 40,000 attendees of this year’s ASCO conference relinquish their hold of the windy city, oncology experts worldwide begin contemplating the wealth of new or expanded data which was presented, and how it might affect their everyday practice. While ASCO 2019 was noticeably focused on prel...

Read More

How to Optimize Your Conversion Funnel, from ToFu to BoFu HOW TO OPTIMIZE YOUR CONVERSION FUNNEL, FROM TOFU TO BOFU

blog article

Jun 24, 2019

No matter who your customer is or what you’re selling, it’s more likely than not that your customer will have to go through several steps before choosing to buy your product or service. Think about your own shopping habits: you don’t just buy the first thing you see. The first thin...

Read More

21 Ways to Triple Your B2B E-Commerce Conversions 21 WAYS TO TRIPLE YOUR B2B E-COMMERCE CONVERSIONS

blog article

Jun 24, 2019

It takes thoughtful work to scale an e-commerce store. I’m sure you’ve had a few growing pains of your own getting to the point where you are today. However, you’re reading this because you may not be content with where your conversions are at this precise moment. You may not even ...

Read More

Could the Breadcrumb Technique Help Boost Your Landing Page Conversions? COULD THE BREADCRUMB TECHNIQUE HELP BOOST YOUR LANDING PAGE CONVERSIONS?

blog article

Jun 24, 2019

We’ve all heard the term “less is more”. And we’ve been told this applies for landing pages too. I.e. your forms should be short and only ask for only the bare minimum of required information if you want to convert. As an example, one of the main questions someone typically h...

Read More

6 Ways to Maximize Product Value as Loss of Exclusivity Approaches 6 WAYS TO MAXIMIZE PRODUCT VALUE AS LOSS OF EXCLUSIVITY APPROACHES

blog article

Jun 24, 2019

Loss of exclusivity does not mean the complete loss of an income stream as drug patent expiration approaches. Steps taken two years before loss of exclusivity can maximize brand value in the meantime. But the arrival of competitors means something different with pharmaceuticals than it does with oth...

Read More

Urgent and labor-intensive: How inadequate drug shortage management tools impact hospital-system pharmacies URGENT AND LABOR-INTENSIVE: HOW INADEQUATE DRUG SHORTAGE MANAGEMENT TOOLS IMPACT HOSPITAL-SYSTEM PHARMACIES

blog article

Jun 24, 2019

Shortages of drugs have become a chronic condition in health-system pharmacies over the last five to seven years, and are a critical issue for both US1,2,3 and European4,5 health-system pharmacies. Excess costs for health systems are generated by higher costs of shorted medications and the extra lab...

Read More

How can AI help in Transforming the Drug Development Cycle? HOW CAN AI HELP IN TRANSFORMING THE DRUG DEVELOPMENT CYCLE?

blog article

Jun 24, 2019

Artificial intelligence (AI) is transforming the pharmaceutical industry with extraordinary innovations that are automating processes at every stage of drug development. Pharma companies are investing in AI-driven applications for transforming healthcare, reducing R&D spends, and expanding the s...

Read More

Can Drug Companies Bribe the FDA? CAN DRUG COMPANIES BRIBE THE FDA?

blog article

Jun 23, 2019

With drugs such as Lipitor achieving lifetime sales well over $100 billion, the motivation to use any means available to ensure drug approval is clear. Bribery of FDA officials has occurred in the past, but is unlikely to occur again for the reasons described below. The overall objective of the drug...

Read More

27-year-old Search Marketing CEO Lands 13-stop U.S. Speaking Tour 27-YEAR-OLD SEARCH MARKETING CEO LANDS 13-STOP U.S. SPEAKING TOUR

blog article

Jun 23, 2019

Digital Summit, the largest conference series in the digital marketing industry, has invited Mehrguth to share his unique presentation, 5 Data-Validated Tactics to Increase the Experienced Marketer’s Qualified Lead Volume (…and 3 Tactics Guaranteed to Fail) with their audiences across t...

Read More

Pharmacovigilance and beyond~old blog with new content PHARMACOVIGILANCE AND BEYOND~OLD BLOG WITH NEW CONTENT

blog article

Jun 23, 2019

After 3 years of a break, I am attempting to restart writing my blog which will cover pharmacovigilance topics, primarily, and whenever appropriate some other relevant topics.  I am deeply thankful to my old readers and followers who kept on contacting me to write the blog again. I am humbled b...

Read More

Maryland Creates Prescription Drug Affordability Board for Setting Price Caps MARYLAND CREATES PRESCRIPTION DRUG AFFORDABILITY BOARD FOR SETTING PRICE CAPS

blog article

Jun 22, 2019

As we have previously reported, the federal government has taken an acute interest in pharmaceutical drug pricing, resulting in a raft of hearings and draft legislation. States are getting on board too, with a Maryland law to go into effect on July 1, 2019, creating a Prescription Drug Affordability...

Read More

5 Ways Clinical Research Can Help You and Your Practice 5 WAYS CLINICAL RESEARCH CAN HELP YOU AND YOUR PRACTICE

blog article

Jun 21, 2019

Conducting clinical trials in one’s private practice—as opposed to hospitals or universities—has become more customary in clinical research. This trend is resulting in patients feeling more comfortable with participating in trials and is also providing physicians with unique benefi...

Read More

Why Life Sciences Companies Should Be Aware Of Its Benefits WHY LIFE SCIENCES COMPANIES SHOULD BE AWARE OF ITS BENEFITS

blog article

Jun 21, 2019

Compliance with regulatory standards does not mean that life sciences companies should ignore ISO standards. We all know that implementing a management system or operational excellence program into a life science company’s workflow isn’t without its costs.

Read More

Pharmaceutical Industry and Blockchain – The Next Big Hit? PHARMACEUTICAL INDUSTRY AND BLOCKCHAIN – THE NEXT BIG HIT?

blog article

Jun 20, 2019

The pharmaceutical industry can use blockchain technology in a wide range of use cases. Drug tracking is currently the most prominent example. The FDA has now teamed up with Walmart and IBM to audit and track drugs in the U.S.

Read More

Why are pharmacy students steering clear of summer placements? WHY ARE PHARMACY STUDENTS STEERING CLEAR OF SUMMER PLACEMENTS?

blog article

Jun 20, 2019

Summer placements for pharmacy students used to be hotly contested. In 2016, the British Pharmaceutical Students’ Association (BPSA) even published my hints and tips on applying for and undertaking these coveted places. They were particularly sought after by third-year pharmacy students, who w...

Read More

Top Drug Companies, Corporation Reputations and Marketing Budgets TOP DRUG COMPANIES, CORPORATION REPUTATIONS AND MARKETING BUDGETS

blog article

Jun 20, 2019

The public’s perception of the drug industry can be confusing. For example, a poll conducted by the Kaiser Family Foundation (KFF) on public opinion on prescription drugs and their prices between 2015 and 2018, found that 80% of the public said the cost of prescription drugs was unreasonable. ...

Read More

No Surprise – Drug Pricing Legislation Picking up Steam NO SURPRISE – DRUG PRICING LEGISLATION PICKING UP STEAM

blog article

Jun 20, 2019

Legislation that addresses the cost of prescription drugs is inching closer to moving out of Congress. On Yesterday, the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing on the bipartisan Lower Health Care Costs Act (LHCCA) discussion draft. Today, the Committee released ...

Read More

Drug Boosts Growth In Youngsters With Most Common Form Of Dwarfism DRUG BOOSTS GROWTH IN YOUNGSTERS WITH MOST COMMON FORM OF DWARFISM

blog article

Jun 19, 2019

A ground breaking drug that helps regulate bone development has boosted growth rates in children with achondroplasia – the most common type of dwarfism – in a global trial led by Melbourne’s Murdoch Children’s Research Institute. Results of the Phase 2 trial in children aged ...

Read More

Digital Therapeutics Can Break Down Barriers to Innovation to Benefit Patients DIGITAL THERAPEUTICS CAN BREAK DOWN BARRIERS TO INNOVATION TO BENEFIT PATIENTS

blog article

Jun 19, 2019

There is rapidly growing and sizeable evidence which shows that innovating is the most important factor in pharmaceuticals. The industry is a field which itself has developed and evolved on the basis of disruption and innovation.

Read More

Pharmacy tests turn up another cancer-causing compound in heart drugs PHARMACY TESTS TURN UP ANOTHER CANCER-CAUSING COMPOUND IN HEART DRUGS

blog article

Jun 19, 2019

Tests by an online pharmacy turned up another cancer-causing compound in heart medications, and these drugs haven't been recalled. Drugs containing valsaratan, losartan and irbesartan made by a variety of companies in a variety of countries have been taken off pharmacy shelves since July, when t...

Read More

Immunotherapy Drug Shows Potential To Cure Advanced Lung Cancer IMMUNOTHERAPY DRUG SHOWS POTENTIAL TO CURE ADVANCED LUNG CANCER

blog article

Jun 18, 2019

In a new study including Yale Cancer Center and Smilow Cancer Hospital researchers, the cancer immunotherapy drug pembrolizumab (Keytruda), increased survival for patients with advanced non-small cell lung cancer (NSCLC), a disease once considered an aggressive, and uniformly fatal cancer. The findi...

Read More

Meet the Top Ten Drugs of 2024 (Maybe) MEET THE TOP TEN DRUGS OF 2024 (MAYBE)

blog article

Jun 18, 2019

The professional prognosticator Evaluate Pharma recently released its World Preview 2019, Outlook to 2024 report, which projects prescription drug sales and R&D activity in the U.S. and abroad. (The report is free with site registration.) You’ll find predictions for the ten best-selling U....

Read More

Sanofi drives digital transformation with Google Cloud SANOFI DRIVES DIGITAL TRANSFORMATION WITH GOOGLE CLOUD

blog article

Jun 18, 2019

My conversations with healthcare customers have made it clear that the industry is moving to a more data-centric model, one that can deliver deeper insights to physicians, help them make better-informed decisions, and provide better care for patients. This transformation goes hand in hand with Googl...

Read More

Bioanalysis at Alliance Pharma BIOANALYSIS AT ALLIANCE PHARMA

blog article

Jun 17, 2019

At Alliance Pharma, our large molecule mass spec group focuses primarily on two areas: protein characterization and low level quantitative bioanalysis. We take pride in our dedication to providing clients with all of the analytical information they need about their protein of interest, with agility ...

Read More

Clinical Evidence Key to Commercializing Life Science Products CLINICAL EVIDENCE KEY TO COMMERCIALIZING LIFE SCIENCE PRODUCTS

blog article

Jun 17, 2019

The days when pharmaceutical sales reps could show up at a doctor’s office with tickets to a baseball game or keys to a company’s beachfront timeshare are long gone. The 2013 federal Sunshine Act and related state laws brought tighter restrictions on payments and other “transfers o...

Read More

Bulgarian Pharmaceutical Scientific Society’s journal moves to high-tech ARPHA platform BULGARIAN PHARMACEUTICAL SCIENTIFIC SOCIETY’S JOURNAL MOVES TO HIGH-TECH ARPHA PLATFORM

blog article

Jun 17, 2019

The established Pharmacia demonstrates a complete makeover in its new issue after signing with scientific publisher and technology provider Pensoft and its signature open-access platform. Launched by the Bulgarian Pharmaceutical Scientific Society in 1954, the open-access, peer-reviewed Pharmacia ha...

Read More

Regulatory Requirements for Early Phase Drug Product Development REGULATORY REQUIREMENTS FOR EARLY PHASE DRUG PRODUCT DEVELOPMENT

blog article

Jun 17, 2019

Supporting a compound from discovery to clinical phases and potentially commercial phases requires an immense amount of time, energy, and money. Regulatory management is paramount during the drug development pipeline funnel, and recognizing Current Good Manufacturing Practices (cGMPs) is the foundat...

Read More

VenatoRx Pharmaceuticals to Present at ASM Microbe 2019 VENATORX PHARMACEUTICALS TO PRESENT AT ASM MICROBE 2019

blog article

Jun 17, 2019

VenatoRx Pharmaceuticals will present ten posters featuring its two development-stage products, cefepime/VNRX-5133 and ceftibuten/VNRX-7145, at ASM Microbe 2019 to be held June 20-24 in San Francisco, CA. VenatoRx will also present an overview if its antibacterial agents portfolio during the Pharma ...

Read More

The Darzi experience THE DARZI EXPERIENCE

blog article

Jun 17, 2019

Between April 2018 and April 2019, Kent Surrey Sussex Academic Health Science Network (KSS AHSN) sponsored the Darzi Fellowship project titled: Leadership role in delivery of KSS AHSN polypharmacy project — improving cross-sector medicines safety, deprescribing support and managing change.

Read More

Data Pipeline Solution Accelerates Pharmaceutical Research DATA PIPELINE SOLUTION ACCELERATES PHARMACEUTICAL RESEARCH

blog article

Jun 17, 2019

Pharmaceutical research is data-intensive. It takes tremendous computational power to parse and analyze the requisite giant chunks of data. The cloud delivers that power and helps accelerate research processes and, ultimately, research findings. That’s why one pharmaceutical company was using ...

Read More

Athletes and Drug Abuse: A Disturbing Trend in Modern Sports ATHLETES AND DRUG ABUSE: A DISTURBING TREND IN MODERN SPORTS

blog article

Jun 15, 2019

Drug abuse is a common occurrence across all types of sports, at all competitive levels. Besides just performance-enhancing drugs such as steroids and stimulants, many athletes feel compelled to abuse drugs and alcohol for a variety of other reasons. The intense pressure to perform, coupled with a p...

Read More

Global Secondary Hyperparathyroidism Drug ### – Deltanoid Pharmaceuticals Inc, EA Pharma Co Ltd, Lupin Ltd GLOBAL SECONDARY HYPERPARATHYROIDISM DRUG ### – DELTANOID PHARMACEUTICALS INC, EA PHARMA CO LTD, LUPIN LTD

blog article

Jun 14, 2019

The “Secondary Hyperparathyroidism Drug Market” far and wide is a standout amongst the most blossoming and colossally sorted division involving. This worldwide Secondary Hyperparathyroidism Drug market has been rising at a higher rate with the advancement of creative procedures and a hei...

Read More

A Look At 4 Cannabis Stocks – AGH, AC8, CAN, CPH A LOOK AT 4 CANNABIS STOCKS – AGH, AC8, CAN, CPH

blog article

Jun 14, 2019

The Cannabis sector is comparatively broad than the expectations of various market research houses, boutique research house or asset managers etc. The prevailing status of cannabis legalisation gradually appears positive, but the market would unleash its further potential, once the legalisation gath...

Read More

Two Cannabis Stocks – THC and MXC – Spike On Recent Updates TWO CANNABIS STOCKS – THC AND MXC – SPIKE ON RECENT UPDATES

blog article

Jun 13, 2019

Medical cannabis is becoming popular in the pharmaceutical industry, with more and more countries legalising cannabis for its use as a medicinal product. Growing number of research bodies are supporting the use of cannabis and cannabis-based products for medical purposes, owing to their ability to t...

Read More

Pharm Country PHARM COUNTRY'S BIOTECH AND PHARMA INDUSTRY FLOURISHES THANKS TO INNOVATIVE LEADERSHIP

blog article

Jun 13, 2019

Efforts undertaken by state and local leaders across the five states that make up Pharm Country have led to a boost in business, which is good news for applicants seeking a new position. Pharm Country, which includes Connecticut, New York, New Jersey, Pennsylvania and Rhode Island, is home to some o...

Read More

Akrevia Therapeutics Appoints Joseph Farmer as Chief Operating Officer AKREVIA THERAPEUTICS APPOINTS JOSEPH FARMER AS CHIEF OPERATING OFFICER

blog article

Jun 12, 2019

Akrevia Therapeutics, a privately-held biopharmaceutical company focused on developing highly-potent, tumor-targeted immuno-oncology therapeutics, today announced that Joseph Farmer has been appointed as Chief Operating Officer. In this newly-established role, Mr. Farmer will lead Akrevia's busi...

Read More

Pharmacists’ role in promoting patient safety through deprescribing PHARMACISTS’ ROLE IN PROMOTING PATIENT SAFETY THROUGH DEPRESCRIBING

blog article

Jun 12, 2019

Pharmacists are obviously key players in prescribing medications. Now, as medication-related harm impacts aging populations, these same pharmacists are being called to take on an equally crucial role in the deprescribing process.

Read More

Aerpio initiates clinical trial of AKB-9778 for treatment of PAOG AERPIO INITIATES CLINICAL TRIAL OF AKB-9778 FOR TREATMENT OF PAOG

blog article

Jun 12, 2019

A US-based pharmaceutical company, Aerpio Pharmaceuticals, Inc., recently announced the initiation of Phase 1b clinical trial of AKB-9778 to develop treatment of PAOG (primary open angle glaucoma), report sources.

Read More

The many benefits of Continuous Manufacturing THE MANY BENEFITS OF CONTINUOUS MANUFACTURING

blog article

Jun 12, 2019

Continuous manufacturing is based on a number of requirements driven by the Pharmaceutical industry; quality, efficiency and speed to market being some of these. Bosch fulfilled these requirements when it released Xelum in 2017. The Xelum platform allows for faster development times and a reduced ri...

Read More

Generic Drug Market Entry in Europe: Why a Tailored Approach Is Best GENERIC DRUG MARKET ENTRY IN EUROPE: WHY A TAILORED APPROACH IS BEST

blog article

Jun 10, 2019

Many government and healthcare authorities across Europe are concerned about rising pharmaceutical prices, and they increasingly promote the use of generics over branded drugs when possible. This is good news for companies interested in generic drug market entry in Europe.

Read More

New tentative approval for Watson Labs drug dienogest; estradiol valerate NEW TENTATIVE APPROVAL FOR WATSON LABS DRUG DIENOGEST; ESTRADIOL VALERATE

blog article

Jun 09, 2019

This ingredient has seventy-three patent family members in thirty-eight countries. Two suppliers are listed for this compound. There is one tentative approval for this compound.

Read More

Which generic companies have the most drugs? WHICH GENERIC COMPANIES HAVE THE MOST DRUGS?

blog article

Jun 09, 2019

Companies that excel in generic drug development tend to also be very good at patent challenge and at developing their own patents on variations of branded drugs.

Read More

Which pharmaceutical companies have the most SPCs in Netherlands? WHICH PHARMACEUTICAL COMPANIES HAVE THE MOST SPCS IN NETHERLANDS?

blog article

Jun 08, 2019

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Netherlands. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long time needed to obtain regulatory approval for drugs. SPCs com...

Read More

Understanding Chemistry of Biologics can Drive Innovation in Pharma UNDERSTANDING CHEMISTRY OF BIOLOGICS CAN DRIVE INNOVATION IN PHARMA

blog article

Jun 07, 2019

The consequences of consuming synthetic drugs (chemicals) are aplenty. The instances of pharmacovigilance keep surfacing, and they tarnish brand value which has long-lasting impact for a pharmaceutical company. As a result, most players developing drugs for complex diseases have ventured into discov...

Read More

Probiotics, do you need them? PROBIOTICS, DO YOU NEED THEM?

blog article

Jun 06, 2019

If stomach upset is frequent or very painful, you should seek medical attention to determine the cause.  Your doctor may be able to determine the cause, or in cases where it is determined to be potentially serious, may refer you to a gastroenterologist for further review.  In some cases, e...

Read More

What Are We Doing About It? A Review of 2019 Legislation to Address the Price of Prescription Drugs in Colorado WHAT ARE WE DOING ABOUT IT? A REVIEW OF 2019 LEGISLATION TO ADDRESS THE PRICE OF PRESCRIPTION DRUGS IN COLORADO

blog article

Jun 06, 2019

In recent years, Colorado lawmakers drafted numerous bills to address the price of prescription drugs. Many of these bills failed because of opposition by Republican Senate leadership, but the 2018 election opened the door for more cost-reduction measures to pass. With the Democratic sweep of state ...

Read More

Your pharmacy calculations prep guide YOUR PHARMACY CALCULATIONS PREP GUIDE

blog article

Jun 06, 2019

All preregistration trainee pharmacists are required to pass a 40-question calculations assessment in two hours. This can be quite daunting especially if you are not prepared.

Read More

JAMA Reports Higher U.S. Brand Drug Prices JAMA REPORTS HIGHER U.S. BRAND DRUG PRICES

blog article

Jun 06, 2019

I’ve recently been exercising bragging rights about our new and improved drug price comparisons. Americans seeking medicine from Canada and other countries are finding better deals on generics right here at home. But the crisis of high drug prices in the U.S. persists when it comes to brand me...

Read More

Regulated cannabis industry would spur healthcare agenda REGULATED CANNABIS INDUSTRY WOULD SPUR HEALTHCARE AGENDA

blog article

Jun 03, 2019

Hemp, the non-psychoactive breed of cannabis, is the most versatile crop known to humans with thousands of uses in industry. Cannabis oil relieves chronic pain in debilitating illnesses such as cancer in both children and adults. Countries are beginning to consider decriminalising and legalising can...

Read More

Healthy lifestyle or Chronic Kidney Disease:The Choice is yours! HEALTHY LIFESTYLE OR CHRONIC KIDNEY DISEASE:THE CHOICE IS YOURS!

blog article

Jun 03, 2019

Chronic kidney disease (CKD) is a growing health problem with an estimated prevalence of around 11.5%.Individuals with CKD are at high risk for progressive kidney failure. End-stage kidney disease leads to considerable human and financial costs with a 5-year survival rate of less than 50%.  The...

Read More

Genocea Biosciences on Top GENOCEA BIOSCIENCES ON TOP

blog article

Jun 02, 2019

Despite the index’s dip, a number of NASDAQ biotech and pharma stocks still had notable share price increases last week. In particular, Genocea Biosciences (NASDAQ:GNCA) spiked on its announcement that the Journal of Clinical Oncology chose the company’s GEN-009 clinical results to be pr...

Read More

Cold Warriors Tanked Big Pharma Regulation COLD WARRIORS TANKED BIG PHARMA REGULATION

blog article

May 31, 2019

With prices climbing for lifesaving drugs like insulin, the regulation of Big Pharma is frequently in the news. Historian Dominique A. Tobbell writes that we’ve been having this debate since the 1950s. Back then, Senator Estes Kefauver, a Tennessee Democrat, became worried about the high price...

Read More

How US Sanctions Hinder Iranians’ Access to Medicine HOW US SANCTIONS HINDER IRANIANS’ ACCESS TO MEDICINE

blog article

May 31, 2019

The United States has over the past four decades imposed a wide range of economic sanctions to punish Iran for a number of undesired policies. While Trump administration officials continue to insist that food and medicine are exempt from US sanctions, and that sanctions do not hurt the Iranian peopl...

Read More

‘Bottle of Lies’ Author Katherine Eban: Dispense as Written ‘BOTTLE OF LIES’ AUTHOR KATHERINE EBAN: DISPENSE AS WRITTEN

blog article

May 31, 2019

“Dispense as Written” are the words found on prescriptions in the U.S. when the prescriber wants the patient to take the brand drug, not the generic. Many who read Katherine Eban’s new book – Bottle of Lies: The Inside Story of the Generic Drug Boom – will conclude that...

Read More

DIGITAL MARKETING STRATEGIES FOR PHARMA IN 2019 DIGITAL MARKETING STRATEGIES FOR PHARMA IN 2019

blog article

May 30, 2019

The digital marketing strategies for pharma companies tend to change pertaining to the region which means the same company needs to adopt different marketing strategies accordingly for its growth.

Read More

Schuh tv drug ads enough to make you sick. SCHUH TV DRUG ADS ENOUGH TO MAKE YOU SICK.

blog article

May 30, 2019

If everyone responded to TV drug ads’ prompts to “ask your doctor” or “check with your physician” about using the product, doctors likely would have no time to treat people. They’d be spending all their working hours answering questions. It used to be that the dog...

Read More

Why Pharma Franchise is a Boon for Small Pharmaceutical Companies? WHY PHARMA FRANCHISE IS A BOON FOR SMALL PHARMACEUTICAL COMPANIES?

blog article

May 30, 2019

Do you own a micro-sized or small company? If yes, then what business model do you think will be ideal when you aim at doing a profitable business?Ask anyone who is an expert in the niche, and you will get the answer, “pharma franchise business.” Statistics also prove the statement. Chec...

Read More

Big Pharma Emits More Greenhouse Gases Than the Automotive Industry BIG PHARMA EMITS MORE GREENHOUSE GASES THAN THE AUTOMOTIVE INDUSTRY

blog article

May 29, 2019

More than 200 companies represent the global pharmaceutical market, yet only 25 consistently reported their direct and indirect greenhouse gas emissions in the past five years. Of those, only 15 reported their emissions since 2012.One immediate and striking result is that the pharmaceutical sector i...

Read More

New Rules for Pharma in Life Sciences NEW RULES FOR PHARMA IN LIFE SCIENCES

blog article

May 29, 2019

Pharma must deliver much more than drugs on the way to a more consumer-oriented industry. Attention on continuous R&D innovation M&A activities often are only one element of pharma companies to maintain or strengthen their position in changing markets. Given the number of changes and challen...

Read More

Matoke Pharma and antimicrobial resistance MATOKE PHARMA AND ANTIMICROBIAL RESISTANCE

blog article

May 29, 2019

Alan joined Matoke Pharma last year, having previous spent 35 years at Bayer, and he explained how that part of his career unfolded, from sales rep to antibiotics clinical research and then to global marketing and brand manager roles before ending with a series of senior management positions.

Read More

Historic trial to weigh big pharma HISTORIC TRIAL TO WEIGH BIG PHARMA'S ROLE IN OPIOID EPIDEMIC BEGINS

blog article

May 28, 2019

Hope for the opioid crisis: It's no secret that opioid deaths and overdoses are at crisis levels in the US. However, 2019 may bring new ways of fighting this epidemic. Every year, the Cleveland Clinic releases the most important medical advancements for the coming year, and at the top of its lis...

Read More

Where Drugs Come From: A Comprehensive Look WHERE DRUGS COME FROM: A COMPREHENSIVE LOOK

blog article

May 28, 2019

On the roles of academia and industry in drug discovery. Which is a topic that refuses to go away. I am prepared to swear that before starting this blog I had no idea of how many people are convinced that the drug industry does little or no research, and that academic labs discover all the drugs. I ...

Read More

Could using old medication kill you? COULD USING OLD MEDICATION KILL YOU?

blog article

May 27, 2019

Winter has arrived and with it colds and flu. If you’re thinking of using meds that have been in the cabinet for months don’t do it. Spokesperson for pharmaceutical company Pharma Dynamics Nicole Jennings says keeping unused medication is not advised as it can lead to misuse and accident...

Read More

Partnering for Sublingual Success PARTNERING FOR SUBLINGUAL SUCCESS

blog article

May 24, 2019

Oral drug delivery has maintained a position of strength within the bio/pharma industry for a number of years, yet challenges associated with oral delivery, such as the harsh conditions of the gastrointestinal tract and enzymatic breakdown, have given rise to the advancement of alternative approache...

Read More

Looking beyond generic, Sun Pharma plans to develop its own medicines LOOKING BEYOND GENERIC, SUN PHARMA PLANS TO DEVELOP ITS OWN MEDICINES

blog article

May 23, 2019

You’d be hard-pressed to find someone who’s lost more during the recent upheaval in the generic drug business than Dilip Shanghvi: He forfeited $17 billion to be precise, plus the title of India’s richest man.After a four-year decline that erased 65 per cent from the value of Sun P...

Read More

PharmacyChecker Generic Drug Price Research Shows U.S. Pharmacies Much Cheaper than in Canada PHARMACYCHECKER GENERIC DRUG PRICE RESEARCH SHOWS U.S. PHARMACIES MUCH CHEAPER THAN IN CANADA

blog article

May 23, 2019

We researched prices of the 40 most commonly dispensed generic drugs in the U.S. to compare them to ones offered at accredited pharmacies in Canada. Four of the generics are controlled drugs, which are not available to U.S. consumers from PharmacyChecker-accredited international online pharmacies; a...

Read More

More Hacks Inevitable in Pharma Industry, Cybersecurity Expert Sayss MORE HACKS INEVITABLE IN PHARMA INDUSTRY, CYBERSECURITY EXPERT SAYSS

blog article

May 22, 2019

Earlier this month, sophisticated cyber thieves hacked into the databases of Charles River Laboratories and compromised some client data. Hacks like this have happened before and they are bound to happen again – perhaps sooner, rather than later.Andrew Douthwaite, chief technology officer for ...

Read More

The Opioid Crisis in America Course from Harvard University THE OPIOID CRISIS IN AMERICA COURSE FROM HARVARD UNIVERSITY

blog article

May 17, 2019

Over 700,000 people died in the U.S. from a drug overdose between 1999 to 2017. That’s about 130 American deaths daily. At PharmacyChecker, we are dedicated to helping fight this epidemic by learning more about the crisis and spreading awareness. I recently obtained certification for The Opioi...

Read More

Vertex and Kymera Therapeutics Establish Strategic Collaboration to Discover and Develop Targeted Protein Degradation Medicines for Serious Diseases VERTEX AND KYMERA THERAPEUTICS ESTABLISH STRATEGIC COLLABORATION TO DISCOVER AND DEVELOP TARGETED PROTEIN DEGRADATION MEDICINES FOR SERIOUS DISEASES

blog article

May 15, 2019

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and Kymera Therapeutics today announced that the two companies have entered into a four-year strategic research and development collaboration to advance small molecule protein degraders against multiple targets. The collaboration will leverage Kymera...

Read More

Zealand’s Severe Hypoglycemia Treatment Hits the Mark in Another Phase III Trial ZEALAND’S SEVERE HYPOGLYCEMIA TREATMENT HITS THE MARK IN ANOTHER PHASE III TRIAL

blog article

May 14, 2019

Denmark-based Zealand said dasiglucagon hit all primary and secondary endpoints in the late-stage trial assessing the safety and efficacy of the glucagon analog for severe hypoglycemia in diabetes patients. Zealand noted that dasiglucagon is a potential first-in-class therapy that is in development ...

Read More

Antibe ANTIBE'S CEO: FOCUSING ON DEVELOPING NON-ADDICTIVE AND NON-TOXIC PAIN TREATMENTS

blog article

May 14, 2019

Toronto-based Antibe is focused on the development of a new generation of therapeutics for severe and acute pain. The company has combined a high-potency NSAID (nonsteroidal anti-inflammatory drug) with cutting-edge science based on inflammation. The result is the company’s lead candidate, ATB...

Read More

Lilly plays up Cyramza LILLY PLAYS UP CYRAMZA'S BIOMARKER EDGE IN CROWDED LIVER CANCER FIELD

blog article

May 13, 2019

It’s been a long road for Eli Lilly’s Cyramza in liver cancer after it belly-flopped a phase 3 trial five years ago. On the back of a successful second attempt, the drugmaker has finally accomplished what once seemed out of reach—but these days, there's a lot more competition i...

Read More

FDA finds testing issues at Torrent plant FDA FINDS TESTING ISSUES AT TORRENT PLANT

blog article

May 13, 2019

A year after Torrent Pharmaceuticals first began recalling tainted losartan products manufactured at its Indrad plant, the FDA paid a visit. It found a plant that often routinely reported products out of specification but frequently shipped them to the U.S. anyway. While the liberal redactions in a ...

Read More

Teva starred in price-fixing scheme, but 19 other companies TEVA STARRED IN PRICE-FIXING SCHEME, BUT 19 OTHER COMPANIES 'WILLINGLY' JOINED, ATTORNEYS GENERAL CLAIM

blog article

May 13, 2019

In what could be "the largest cartel case in the history of the United States," as Connecticut Attorney General William Tong called it, 44 states sued 20 generics makers on Friday for price fixing and personally named 15 of those companies' executives.

Read More

FDA FDA'S FINALIZED BIOSIM INTERCHANGEABILITY RULES SHOULD GIVE COPYCATS A BOOST: ANALYST

blog article

May 13, 2019

Biosimilars have been sold in the U.S. for years but haven't managed to gain much traction. One reason? Unlike generics of small molecules, biosimilars can't be automatically substituted at the pharmacy unless clinical data prove interchangeability with their reference products.

Read More

Don Van Dyke on the power of AI to transform drug discovery efficiency DON VAN DYKE ON THE POWER OF AI TO TRANSFORM DRUG DISCOVERY EFFICIENCY

blog article

May 13, 2019

In recent years, it has been hotly debated whether artificial intelligence really has the power to transform the drug discovery space. Cloud Pharmaceuticals believes that not only is there potential for this change but that they are already seeing the impact first hand. Having used their own technol...

Read More

NABP-Accredited Rochester Drug Cooperative Pleads Guilty to Illegal Opioid Drug Sales NABP-ACCREDITED ROCHESTER DRUG COOPERATIVE PLEADS GUILTY TO ILLEGAL OPIOID DRUG SALES

blog article

May 10, 2019

Rochester Drug Cooperative, a large pharmacy wholesaler accredited by the National Association of Boards of Pharmacy (NABP), pleaded guilty last week to illegal sales of opioid drugs, including oxycodone and fentanyl. The NABP operates a program called Verified Authorized Wholesale Distribution (VAW...

Read More

Can pharma survive as data-driven therapy takes centre stage? CAN PHARMA SURVIVE AS DATA-DRIVEN THERAPY TAKES CENTRE STAGE?

blog article

May 08, 2019

Payment-by-outcomes and digital therapeutics (DTx) count among the serious challenges the pharma industry must negotiate in the coming years. They have the potential to change what healthcare industry reimburses. Rather than a drug alone, it will seek a package of drug, digital services and digital ...

Read More

Cancer Prevention Pharmaceuticals (CPP) and Mallinckrodt Announce Results from Pivotal CANCER PREVENTION PHARMACEUTICALS (CPP) AND MALLINCKRODT ANNOUNCE RESULTS FROM PIVOTAL

blog article

May 07, 2019

United Kingdom, May 7, 2019 /PRNewswire/ -- Cancer Prevention Pharmaceuticals, Inc. (CPP), a private biotech company developing novel therapeutics to prevent cancer and other diseases, and its partner Mallinckrodt Plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced th...

Read More

Writing competition now open: tell us about the patient who changed your practice WRITING COMPETITION NOW OPEN: TELL US ABOUT THE PATIENT WHO CHANGED YOUR PRACTICE

blog article

May 07, 2019

It could be about an error you missed, a question you should have asked or an unexpectedly positive outcome to a interaction you will never forget — some patients teach a valuable lesson that endures for an entire professional career. The Pharmaceutical Journal is now accepting entries for its...

Read More

Drug-Patent Rules, Alleged Abuses Under Senate Panel’s Scrutiny DRUG-PATENT RULES, ALLEGED ABUSES UNDER SENATE PANEL’S SCRUTINY

blog article

May 07, 2019

Federal patent rules and the debate over whether they make prescription drugs more expensive are set to take center stage at a Senate hearing today. Sen. John Cornyn (R-Texas) is leading a push to see if pharmaceutical companies are abusing federal laws to extend the life of their patents and fend o...

Read More

The Emerging Time Of An African Court Of Law THE EMERGING TIME OF AN AFRICAN COURT OF LAW

blog article

May 06, 2019

Open indictment of genocide and other crimes committed by white collor scientists in collaboration with governmental, medical, military and pharmaceutical establishments against Africans On the 4th of July, what a remarkable date, 2011, it becomes known that more and more African leaders and militar...

Read More

New Study Shows International Online Pharmacies Are Safe As U.S. Pharmacies NEW STUDY SHOWS INTERNATIONAL ONLINE PHARMACIES ARE SAFE AS U.S. PHARMACIES

blog article

May 05, 2019

Roger Bate, a scholar at the American Enterprise Institute and head of the Safe Medicines Coalition, published the results of a study which tested and compared the quality of drugs purchased from online pharmacies in the U.S. and abroad, including pharmacies verified by third-parties and those not v...

Read More

GSK chases Trelegy asthma nod with mixed phase 3 results GSK CHASES TRELEGY ASTHMA NOD WITH MIXED PHASE 3 RESULTS

blog article

May 03, 2019

With generics attacking Advair, GlaxoSmithKline has talked up prospects for 3-in-1 respiratory med Trelegy. Now, the company has data in hand that could help it move into the asthma arena—though it's not all positive. Thursday, GSK released phase 3 trial data showing Trelegy had topped Bre...

Read More

Pill Presses and Counterfeit Prescription Narcotics: Supporting the STEER Act PILL PRESSES AND COUNTERFEIT PRESCRIPTION NARCOTICS: SUPPORTING THE STEER ACT

blog article

May 03, 2019

In their opposition to drug importation legislation, the myriad “non-profit” groups funded by drug companies often cynically invoke the evils of counterfeit drugs. We’ve seen this as recently as this week, when an importation bill triumphantly passed in Florida (Prescription Drug I...

Read More

Protein analysis uncovers new targets for improving immuno-oncology in colon cancer PROTEIN ANALYSIS UNCOVERS NEW TARGETS FOR IMPROVING IMMUNO-ONCOLOGY IN COLON CANCER

blog article

Apr 29, 2019

Over the past decade, oncology research has ushered in tremendous advances in the understanding of genes that can mutate and cause cancer. But what, exactly, is going awry with those genes that leads to this destructive disease process? A new analysis focusing on 8,000 proteins involved in colon can...

Read More

Abbott spotlights study data showing its troponin blood test can predict heart disease risks years ahead ABBOTT SPOTLIGHTS STUDY DATA SHOWING ITS TROPONIN BLOOD TEST CAN PREDICT HEART DISEASE RISKS YEARS AHEAD

blog article

Apr 29, 2019

While the presence of high levels of troponin in the bloodstream has been used to help detect acute heart attacks in the emergency room, Abbott says that new study data employing its high-sensitivity test could predict a person’s chances of having a cardiac event years into the future, even in...

Read More

AliveCor’s mobile ECG receives FDA clearances for 2 additional arrhythmias ALIVECOR’S MOBILE ECG RECEIVES FDA CLEARANCES FOR 2 ADDITIONAL ARRHYTHMIAS

blog article

Apr 26, 2019

AliveCor has secured two additional FDA clearances for its personal electrocardiogram, allowing it to detect bradycardia and tachycardia arrhythmias. Along with its previous 510(k) clearance for atrial fibrillation, the company’s KardiaMobile device is now the only consumer-focused product tha...

Read More

From the Ashes of Scandal, Bausch Health Moves Ahead With Psoriasis Approval FROM THE ASHES OF SCANDAL, BAUSCH HEALTH MOVES AHEAD WITH PSORIASIS APPROVAL

blog article

Apr 26, 2019

Bausch Health, formerly known as Valeant Pharmaceuticals International, announced that the U.S. Food and Drug Administration (FDA) had approved its Duobrii (halobetasol propionate and tazoretene) Lotion for plaque psoriasis. The drug, developed by a Bausch division, Ortho Dermatologics, was rejected...

Read More

Will pharmacy become a five-year degree? WILL PHARMACY BECOME A FIVE-YEAR DEGREE?

blog article

Apr 25, 2019

“This is the biggest change in pharmacy education and training since the profession moved in the mid-20th century from the apprenticeship route to become a degree-only profession,” says Marc Donovan, chief pharmacist at Boots. But the proposals from the General Pharmaceutical Council (GP...

Read More

FDA clears Current Health’s hospital-to-home wearable, combining analytics and passive vital sign tracking FDA CLEARS CURRENT HEALTH’S HOSPITAL-TO-HOME WEARABLE, COMBINING ANALYTICS AND PASSIVE VITAL SIGN TRACKING

blog article

Apr 25, 2019

The FDA has cleared Current Health’s wearable tracker, designed to be taken home from the hospital after acute care to track a patient’s recovery in real time, with the ultimate goal of reducing readmissions. The 510(k) clearance covers the Class II device and Current’s telehealth ...

Read More

DNA Repair and Transcription: A Balancing Act DNA REPAIR AND TRANSCRIPTION: A BALANCING ACT

blog article

Apr 25, 2019

Transcription is the process by which DNA is converted into messenger RNA in preparation for translation into a functional product. Extrinsic agents, such as ionizing radiation or chemical mutagen and intrinsic processes, for example, replication fork collapse, may result in cellular double-stranded...

Read More

Do Google & Bing censor online pharmacy search results? Pharmaceutical companies have called for censorship. DO GOOGLE & BING CENSOR ONLINE PHARMACY SEARCH RESULTS? PHARMACEUTICAL COMPANIES HAVE CALLED FOR CENSORSHIP.

blog article

Apr 25, 2019

Until we lower drug prices here at home in America, online access to affordable medication internationally is clearly essential. But what if we lived in a country where people were no longer able to find safe international options online? In an ideal world, search algorithms empower consumers to fin...

Read More

The Role of the CD38 Receptor in the Progression of HIV THE ROLE OF THE CD38 RECEPTOR IN THE PROGRESSION OF HIV

blog article

Apr 24, 2019

CD38, or cyclic ADP ribose hydrolase, is a glycoprotein found on the surface of many immune cells. Binding of CD38 to its target ligand results in T cell co-stimulation, B cell maturation, and induction of cytokine production by several cell types. HIV infection is characterized by the depletion of ...

Read More

Targeted Proteomics: Benefits and Techniques TARGETED PROTEOMICS: BENEFITS AND TECHNIQUES

blog article

Apr 24, 2019

The proteome of the cell genome is more insightful compared to its transcriptome as proteins directly determine and alter cellular function. Post‐translational modification of existing proteins, increased abundance or allosterically modulated protein conformations have been tied to complex diseases,...

Read More

On the importance of culture, partnerships and diversity at the Dean’s Lecture Series ON THE IMPORTANCE OF CULTURE, PARTNERSHIPS AND DIVERSITY AT THE DEAN’S LECTURE SERIES

blog article

Apr 23, 2019

When pharmaceutical companies align their research endeavors with academic institutions, they are most likely to translate their findings quickly and safely into beneficial treatments for patients, said Emma Walmsley, CEO of GlaxoSmithKline, at a recent talk on campus as part of the Dean's Lectu...

Read More

Can a blood pressure drug protect the brain from Parkinson CAN A BLOOD PRESSURE DRUG PROTECT THE BRAIN FROM PARKINSON'S?

blog article

Apr 23, 2019

A prescription drug already in use for the treatment of high blood pressure could be effective against conditions such as Parkinson's, Alzheimer's, and Huntington's, in which toxic proteins build up in brain cells. Scientists at the University of Cambridge in the United Kingdom and the G...

Read More

Should pharmacy sell e-cigarettes and encourage people to vape? SHOULD PHARMACY SELL E-CIGARETTES AND ENCOURAGE PEOPLE TO VAPE?

blog article

Apr 23, 2019

A smoking cessation expert and a pharmacist share their views on whether pharmacies should stock and recommend e-cigarettes to people who want to kick their tobacco habit. It’s been more than ten years since the UK’s public smoking ban pushed cigarette smokers out into the cold in 2007, ...

Read More

PathAI raises $60M for deep learning-based pathology programs PATHAI RAISES $60M FOR DEEP LEARNING-BASED PATHOLOGY PROGRAMS

blog article

Apr 22, 2019

To help power its artificial intelligence-based pathology services, PathAI has raised $60 million in venture capital funding, with plans to accelerate its R&D into new digital tools and medical devices for the diagnosis and classification of diseases like cancer. In addition, the Boston-based co...

Read More

How Germany Gets Its Cannabis HOW GERMANY GETS ITS CANNABIS

blog article

Apr 22, 2019

The German cannabis cultivation bid may be mostly done and dusted (although the last four lots are now up for legal challenge) but the drama is only intensifying on the ground in Germany. Namely, where is the cannabis being consumed on the ground now actually coming from? For the past several years ...

Read More

Big Pharma Cuts, Current and Coming BIG PHARMA CUTS, CURRENT AND COMING

blog article

Apr 22, 2019

Word came out just before the weekend (first at Endpoints) that GlaxoSmithKline is laying off R&D employees at both Stevenage (UK) and Upper Providence (US). Current leadership is re-organizing drug discovery efforts to put more emphasis on oncology, immunology and genetic-linked disease, and th...

Read More